subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil


subject: CHEBI:190410

subject_name: 13-Demethyl tacrolimus

object_name: Unresectable Hepatocellular Carcinoma

tested_intervention: unsure


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:63635

subject_name: Valganciclovir

object_name: cytomegalovirus infection

tested_intervention: yes


subject: UNII:BN93L2NT5I

object_name: rosacea


subject: CHEMBL.COMPOUND:CHEMBL4297709


subject: UMLS:C5854526

subject_name: Irinotecan Liposome HR070803

object_name: pancreatic neoplasm


subject: UMLS:C5854526

object_name: exocrine pancreatic carcinoma


subject: UMLS:C5854526

object_name: malignant pancreatic neoplasm


subject: PUBCHEM.COMPOUND:135436482

subject_name: Calcium folinate


subject: PUBCHEM.COMPOUND:135436482


subject: PUBCHEM.COMPOUND:135436482


subject: CHEBI:135752

subject_name: Tafenoquine

object_name: Malaria, Vivax


subject: CHEBI:93274

subject_name: Fluvoxamine

object_name: Cancer patients and suicide and depression


subject: CHEBI:93274

object_name: Depressed - symptom


subject: CHEBI:93274

object_name: Depression, CTCAE


subject: CHEBI:168396

subject_name: Mycophenolic acid

object_name: systemic sclerosis


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:63791

subject_name: Lenalidomide

object_name: primary central nervous system lymphoma


subject: CHEBI:75929

object_name: post-traumatic stress disorder


subject: CHEBI:40009

subject_name: Cycloserine


subject: CHEBI:17650

subject_name: Hydrocortisone


subject: UNII:KXG2PJ551I

subject_name: Avelumab

object_name: Metastatic non-small cell lung cancer


subject: UMLS:C3896806


subject: DRUGBANK:DB17901

object_name: Duchenne muscular dystrophy


subject: CHEMBL.COMPOUND:CHEMBL5314348

subject_name: BIVALIRUDIN

object_name: Aortic stenosis, severe


subject: UMLS:C1314413

subject_name: INJECTION, BIVALIRUDIN, 1 MG ADMINISTERED


subject: CHEBI:59173

subject_name: Bivalirudin


subject: UNII:897NVD4A52

subject_name: p-Chloroamphetamine

object_name: bone marrow failure syndrome


subject: UNII:897NVD4A52

object_name: pulmonary fibrosis and/or bone marrow failure, Telomere-related, 2


subject: UNII:897NVD4A52

object_name: aplastic anemia


subject: UNII:897NVD4A52

object_name: idiopathic aplastic anemia


subject: UNII:897NVD4A52

object_name: leukemia


subject: UNII:897NVD4A52

object_name: childhood leukemia


subject: UNII:897NVD4A52

object_name: severe combined immunodeficiency


subject: CHEBI:62248


subject: CHEBI:62248


subject: CHEBI:62248


subject: CHEBI:62248


subject: CHEBI:62248


subject: CHEBI:62248


subject: CHEBI:62248


subject: CHEBI:36751


subject: CHEBI:36751


subject: CHEBI:36751


subject: CHEBI:36751


subject: CHEBI:36751


subject: CHEBI:36751


subject: CHEBI:36751


subject: CHEBI:16010


subject: CHEBI:16010


subject: CHEBI:16010


subject: CHEBI:16010


subject: CHEBI:16010


subject: CHEBI:16010


subject: CHEBI:16010


subject: UMLS:C0034330

subject_name: Pidolic acid


subject: UMLS:C0034330


subject: UMLS:C0034330


subject: UMLS:C0034330


subject: UMLS:C0034330


subject: UMLS:C0034330


subject: UMLS:C0034330


subject: CHEBI:167309

subject_name: Methadone


subject: CHEBI:167309


subject: CHEBI:167309


subject: CHEBI:167309


subject: CHEBI:167309


subject: CHEBI:167309


subject: CHEBI:167309


subject: MESH:D056692

subject_name: Prebiotics

object_name: Yeast infection


subject: MESH:D056692

object_name: bacterial vaginosis


subject: CHEBI:73272

subject_name: CANAGLIFLOZIN

object_name: Androgen excess


subject: PUBCHEM.COMPOUND:74323022

subject_name: Canagliflozin


subject: CHEBI:145499

subject_name: Donepezil

object_name: fragile X syndrome


subject: CHEBI:36704

subject_name: Imiquimod

object_name: diffuse midline glioma, H3 K27M-mutant


subject: CHEBI:36704

object_name: diffuse intrinsic pontine glioma


subject: CHEBI:16664

subject_name: Albendazole

object_name: anemia


subject: CHEBI:16664

object_name: malaria


subject: CHEBI:16664

object_name: Hepatosplenomegaly


subject: CHEBI:45267

subject_name: praziquantel


subject: CHEBI:45267


subject: CHEBI:45267


subject: CHEBI:91583

subject_name: Praziquantel


subject: CHEBI:91583


subject: CHEBI:91583


subject: PUBCHEM.COMPOUND:66586232

object_name: Multidrug resistant bacterial infection


subject: CHEBI:3614

subject_name: Chlorhexidine


subject: UMLS:C0008586

subject_name: Chromogranins


subject: PUBCHEM.COMPOUND:5281767

subject_name: CURCUMIN

object_name: Mental deterioration


subject: PUBCHEM.COMPOUND:5281767

object_name: Cognitive impairment


subject: UMLS:C5564711

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UMLS:C5564711

object_name: obesity


subject: UMLS:C5564711

object_name: Obesity, CTCAE


subject: UMLS:C5564711

object_name: type 2 diabetes mellitus


subject: CHEBI:42797

subject_name: Gabapentin

object_name: Nystagmus


subject: CHEBI:42797

object_name: congenital nystagmus


subject: CHEBI:42797

object_name: Nystagmus, CTCAE 5.0


subject: CHEBI:42797

object_name: Nystagmus, CTCAE 3.0


subject: CHEBI:64312

subject_name: Memantine


subject: CHEBI:64312


subject: CHEBI:64312


subject: CHEBI:64312


subject: PUBCHEM.COMPOUND:544190

object_name: end stage renal failure


subject: PUBCHEM.COMPOUND:544190

object_name: Chronic uremia


subject: CHEBI:7798

subject_name: Oseltamivir


subject: CHEBI:7798


subject: UMLS:C2958908

subject_name: Injection, denosumab, 1 mg administered

object_name: Allergy to denosumab


subject: UMLS:C2958908

object_name: Allergy to zoledronic acid


subject: UMLS:C5203422

subject_name: Denosumab Liquid Injection


subject: UMLS:C5203422


subject: UNII:4EQZ6YO2HI

subject_name: Denosumab


subject: UNII:4EQZ6YO2HI


subject: CHEBI:8378

subject_name: Prednisolone

object_name: COPD, severe early onset


subject: CHEBI:8378

object_name: chronic obstructive pulmonary disease


subject: UMLS:C3493856


subject: UMLS:C3493856


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: acute coronary syndrome


subject: CHEBI:39548

object_name: inherited lipid metabolism disorder


subject: CHEBI:38545

subject_name: Rosuvastatin


subject: CHEBI:38545


subject: CHEBI:38545

object_name: Dyslipidemia


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: relapsed/refractory diffuse large B-cell lymphoma


subject: UNII:52CMI0WC3Y

object_name: Diffuse large B-cell lymphoma recurrent


subject: UNII:52CMI0WC3Y

object_name: Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma


subject: UNII:52CMI0WC3Y

object_name: Refractory Transformed Non-Hodgkin Lymphoma


subject: UNII:52CMI0WC3Y

object_name: Non-Hodgkin's lymphoma transformed recurrent


subject: UNII:52CMI0WC3Y

object_name: Richter syndrome


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: CHEBI:175901

subject_name: Gemcitabine


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: CHEMBL.COMPOUND:CHEMBL5314979

object_name: atopic eczema


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: post-traumatic stress disorder


subject: CHEBI:28939

object_name: alcohol abuse


subject: CHEBI:28939

object_name: Addiction


subject: CHEBI:7421

subject_name: NAC


subject: CHEBI:7421


subject: CHEBI:7421


subject: PUBCHEM.COMPOUND:135449332

subject_name: Eltrombopag

object_name: autoimmune thrombocytopenia


subject: GTOPDB:7970

subject_name: depatuxizumab mafodotin

object_name: glioblastoma


subject: GTOPDB:7970

object_name: Childhood Glioblastoma


subject: GTOPDB:7970

object_name: adult glioblastoma


subject: GTOPDB:7970

object_name: Adult Gliosarcoma


subject: GTOPDB:7970

object_name: gliosarcoma


subject: GTOPDB:7970

object_name: Childhood Gliosarcoma


subject: UNII:F3R7A4P04N


subject: UNII:F3R7A4P04N


subject: UNII:F3R7A4P04N


subject: UNII:F3R7A4P04N


subject: UNII:F3R7A4P04N


subject: UNII:F3R7A4P04N


subject: UMLS:C4477221


subject: UMLS:C4477221


subject: UMLS:C4477221


subject: UMLS:C4477221


subject: UMLS:C4477221


subject: UMLS:C4477221


subject: CHEBI:91400

subject_name: Afatinib

object_name: squamous cell carcinoma


subject: UMLS:C0445115

subject_name: Normal saline

object_name: Ruptured Appendicitis


subject: UMLS:C0445115

object_name: Acute perforated appendicitis


subject: UMLS:C0445115

object_name: Appendicitis Perforated, CTCAE


subject: UNII:X00B0D5O0E

subject_name: PIPERACILLIN


subject: UNII:X00B0D5O0E


subject: UNII:X00B0D5O0E


subject: CHEBI:8232

subject_name: Piperacillin


subject: CHEBI:8232


subject: CHEBI:8232


subject: CHEBI:9421

subject_name: Tazobactam


subject: CHEBI:9421


subject: CHEBI:9421


subject: CHEBI:77602

object_name: impotence


subject: CHEBI:77602

object_name: Unable to perform sex


subject: CHEBI:5137

subject_name: fluvastatin sodium


subject: CHEBI:5137


subject: CHEBI:95159


subject: CHEBI:95159


subject: CHEBI:38562

subject_name: Fluvastatin


subject: CHEBI:38562


subject: GTOPDB:4942

subject_name: GM-CSF

object_name: prostate carcinoma


subject: GTOPDB:4942

object_name: prostate cancer


subject: UMLS:C0376563

subject_name: Recombinant Granulocyte-Macrophage Colony-Stimulating Factors


subject: UMLS:C0376563


subject: PUBCHEM.COMPOUND:3962

object_name: inherited lipid metabolism disorder


subject: PUBCHEM.COMPOUND:3962

object_name: Dyslipidemia


subject: PUBCHEM.COMPOUND:3962

object_name: hyperlipidemia


subject: PUBCHEM.COMPOUND:3962

object_name: hyperlipoproteinemia


subject: PUBCHEM.COMPOUND:3962

object_name: Hyperlipidemia, CTCAE


subject: PUBCHEM.COMPOUND:3962

object_name: Serum lipids high (finding)


subject: PUBCHEM.COMPOUND:3962

object_name: hyperlipidemia, familial combined, LPL related


subject: PUBCHEM.COMPOUND:3962

object_name: Mixed hyperlipidemia (disorder)


subject: PUBCHEM.COMPOUND:3962

object_name: Mixed Hyperlipidemia


subject: CHEBI:40303

subject_name: Lovastatin


subject: CHEBI:40303


subject: CHEBI:40303


subject: CHEBI:40303


subject: CHEBI:40303


subject: CHEBI:40303


subject: CHEBI:40303


subject: CHEBI:40303


subject: CHEBI:40303


subject: CHEBI:24261

subject_name: glucocorticoid

object_name: limb-girdle muscular dystrophy


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina

object_name: Depressive Symptoms


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: UMLS:C3265062


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UNII:D6OMY2L0WA

subject_name: Epcoritamab

object_name: chronic lymphocytic leukemia/small lymphocytic lymphoma


subject: UNII:D6OMY2L0WA

object_name: B-cell chronic lymphocytic leukemia


subject: UNII:D6OMY2L0WA

object_name: chronic leukemia


subject: UNII:D6OMY2L0WA

object_name: CLL variants


subject: UNII:D6OMY2L0WA

object_name: Small Lymphocytic Lymphoma Variant


subject: UMLS:C5206892

subject_name: epcoritamab


subject: UMLS:C5206892


subject: UMLS:C5206892


subject: UMLS:C5206892


subject: UMLS:C5206892


subject: CHEBI:6931

subject_name: Midazolam


subject: PUBCHEM.COMPOUND:162396309


subject: CHEBI:50859

subject_name: Bexarotene

object_name: leukemia


subject: CHEBI:50859

object_name: childhood leukemia


subject: CHEBI:50859

object_name: Myelodysplasia


subject: CHEBI:50859


subject: UNII:5TAA004E22

subject_name: Sargramostim


subject: UNII:5TAA004E22


subject: PR:000005931


subject: PR:000005931


subject: UMLS:C5237178

object_name: kidney failure


subject: UMLS:C5237178

object_name: kidney disorder


subject: UMLS:C5237178

object_name: Injury of kidney


subject: CHEBI:88339

object_name: Childhood Breast Carcinoma


subject: CHEBI:88339

object_name: breast carcinoma


subject: CHEBI:88339

object_name: breast cancer


subject: UMLS:C0059079

subject_name: EMLA

object_name: leukemia; lymphoma


subject: CHEBI:6456

subject_name: Lidocaine


subject: UMLS:C1541530

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C1541530

object_name: Metastatic malignant neoplasm to liver


subject: CHEBI:8988

object_name: brain neoplasm


subject: CHEBI:8988

object_name: Childhood Neuroblastoma


subject: CHEBI:8988

object_name: neuroblastoma


subject: CHEBI:8988

object_name: pediatric osteosarcoma


subject: CHEBI:8988

object_name: Osteosarcoma


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside


subject: PUBCHEM.COMPOUND:131769963


subject: PUBCHEM.COMPOUND:131769963


subject: PUBCHEM.COMPOUND:131769963


subject: PUBCHEM.COMPOUND:131769963


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: PUBCHEM.COMPOUND:152165

object_name: ankylosing spondylitis


subject: CHEBI:47381

subject_name: Diclofenac


subject: CHEBI:4325

subject_name: Dapsone

object_name: Pemphigoid


subject: CHEBI:49040

subject_name: Ezetimibe

object_name: Dyslipidemia


subject: CHEBI:71219

subject_name: Pazopanib

object_name: Stage II Renal Cell Cancer AJCC v8


subject: CHEBI:71219

object_name: Stage II Renal Cell Cancer


subject: CHEBI:71219

object_name: Stage II Renal Cell Cancer AJCC v7


subject: CHEBI:71219

object_name: Stage I Renal Cell Cancer AJCC v8


subject: CHEBI:71219

object_name: Stage I Renal Cell Carcinoma


subject: CHEBI:71219

object_name: Stage III Renal Cell Cancer AJCC v8


subject: CHEBI:71219

object_name: Stage III renal cell cancer


subject: CHEBI:71219

object_name: Stage III Renal Cell Cancer AJCC v7


subject: CHEBI:71219

object_name: nonpapillary renal cell carcinoma


subject: CHEBI:71219

object_name: clear cell renal carcinoma


subject: UMLS:C0935796

subject_name: Annamycin Liposomal

object_name: acute myeloid leukemia


subject: UMLS:C0935796

object_name: acute lymphoblastic leukemia


subject: CHEBI:5864

subject_name: Ifosfamide

object_name: Adult Rhabdomyosarcoma


subject: CHEBI:5864

object_name: rhabdomyosarcoma


subject: CHEBI:5864

object_name: Childhood Rhabdomyosarcoma


subject: CHEBI:5864

object_name: Previously Treated Childhood Rhabdomyosarcoma


subject: UNII:T5IRO3534A

subject_name: Oncovin


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: PUBCHEM.COMPOUND:3717450

subject_name: Leurocristine


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: UMLS:C0591904


subject: UMLS:C0591904


subject: UMLS:C0591904


subject: UMLS:C0591904


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:47898

subject_name: Epirubicin


subject: CHEBI:47898


subject: CHEBI:47898


subject: CHEBI:47898


subject: CHEBI:31355

subject_name: Carboplatin


subject: CHEBI:31355


subject: CHEBI:31355


subject: CHEBI:31355


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:63925

subject_name: PhXa 85

object_name: ocular hypertension


subject: CHEBI:63925

object_name: Ocular hypertension


subject: UMLS:C2933875

subject_name: AERAS 485

object_name: tuberculosis


subject: UMLS:C0085826

subject_name: Antiplatelet Agents

object_name: coronary stenosis


subject: UMLS:C0085826

object_name: coronary artery disorder


subject: UMLS:C0085826

object_name: coronary atherosclerosis


subject: UNII:4058H365ZB

subject_name: Fiacitabine

object_name: cytomegalovirus infection


subject: UNII:4058H365ZB

object_name: HIV infection


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: cerebral palsy


subject: UNII:1L8QUK35RX

object_name: Alzheimer disease


subject: UNII:15C2VL427D

subject_name: Aflibercept

object_name: macular degeneration


subject: UNII:15C2VL427D

object_name: retinitis pigmentosa 30


subject: CHEBI:83766

subject_name: Olaparib

object_name: pancreatic acinar cell carcinoma


subject: CHEBI:83766

object_name: Pancreas carcinoma resectable


subject: CHEBI:83766

object_name: Resectable Pancreatic Acinar Cell Carcinoma


subject: CHEBI:83766

object_name: Pancreatic adenocarcinoma resectable


subject: CHEBI:83766

object_name: Resectable Pancreatic Adenosquamous Carcinoma


subject: CHEBI:83766

object_name: pancreatic adenosquamous carcinoma


subject: CHEBI:83766

object_name: squamous cell carcinoma of pancreas


subject: CHEBI:231678

subject_name: Evofosfamide

object_name: pancreatic adenocarcinoma


subject: UNII:L63605PZ70

subject_name: TALAPORFIN SODIUM

object_name: benign prostatic hyperplasia


subject: UNII:L63605PZ70

object_name: lower urinary tract symptom


subject: UMLS:C1312955

subject_name: talaporfin sodium


subject: UMLS:C1312955


subject: CHEBI:135875

subject_name: Talaporfin


subject: CHEBI:135875


subject: CHEBI:231683

subject_name: Anakinra

object_name: Fatigue, CTCAE 5.0


subject: CHEBI:231683

object_name: Fatigue


subject: UNII:9013DUQ28K


subject: UNII:9013DUQ28K


subject: PR:000001137

subject_name: interleukin-1 receptor antagonist protein


subject: PR:000001137


subject: CHEBI:49575

subject_name: Diazepam

object_name: Uses contraception (finding)


subject: CHEBI:6456

subject_name: Lidocaine


subject: CHEBI:233362

subject_name: Abemaciclib

object_name: breast neoplasm


subject: CHEBI:4953

subject_name: Exemestane

object_name: Neoplasm Metastasis


subject: UNII:9CXQ3PF69U

subject_name: Imlunestrant


subject: UNII:9CXQ3PF69U


subject: UMLS:C1310928

object_name: graft versus host disease


subject: UMLS:C1310928

object_name: cancer


subject: UMLS:C1310928

object_name: neoplasm


subject: UNII:8K80YB5GMG

subject_name: Rilonacept

object_name: gout


subject: UMLS:C2343505

subject_name: Arcalyst


subject: UNII:WG93X96336

subject_name: Briciclib

object_name: Advanced Malignant Solid Neoplasm


subject: UNII:WG93X96336


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus

object_name: prostate carcinoma


subject: PUBCHEM.COMPOUND:70789204

object_name: prostate cancer


subject: CHEBI:8405

subject_name: Primaquine

object_name: Plasmodium vivax infection


subject: UMLS:C0042210

subject_name: Vaccines

object_name: hepatitis


subject: UMLS:C0042210

object_name: hepatitis B


subject: UMLS:C0042210

object_name: viral hepatitis


subject: UMLS:C5399710

subject_name: Vaccine [APC]


subject: UMLS:C5399710


subject: UMLS:C5399710


subject: PUBCHEM.COMPOUND:1972

subject_name: Fungizone

object_name: invasive aspergillosis


subject: CHEBI:2682

subject_name: Amphotericin B


subject: DRUGBANK:DB16481

subject_name: Dociparstat sodium


subject: DRUGBANK:DB16481

object_name: acute respiratory distress syndrome


subject: DRUGBANK:DB16481

object_name: acute lung injury


subject: UNII:4O75889WF4


subject: UNII:4O75889WF4


subject: UNII:4O75889WF4


subject: CHEBI:135652

subject_name: Flunarizine

object_name: migraine


subject: CHEBI:135652

object_name: migraine with or without aura, susceptibility to, 1


subject: CHEBI:17933

subject_name: Calcifediol

object_name: vitamin D deficiency


subject: CHEBI:17933

object_name: secondary hyperparathyroidism of renal origin


subject: CHEBI:17933

object_name: Stage 4 chronic kidney disease


subject: CHEBI:17933

object_name: Stage 3 chronic kidney disease


subject: CHEBI:31401

subject_name: Cilostazol

object_name: brain small vessel disease 3


subject: CHEBI:31401

object_name: Lacunar stroke


subject: CHEBI:6062

subject_name: Isosorbide mononitrate


subject: CHEBI:6062


subject: CHEBI:132774

subject_name: Roxadustat

object_name: heart failure


subject: CHEBI:132774

object_name: Heart Failure, CTCAE


subject: CHEBI:132774

object_name: chronic kidney disease


subject: CHEBI:132774

object_name: anemia


subject: CHEBI:132774

object_name: Anemia, CTCAE


subject: UMLS:C3713379


subject: UMLS:C3713379


subject: UMLS:C3713379


subject: UMLS:C3713379


subject: UMLS:C3713379


subject: PUBCHEM.COMPOUND:4240

subject_name: Mometasone furoate

object_name: chronic rhinosinusitis


subject: CHEBI:6970

subject_name: Mometasone


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: Recurrent Merkel Cell Carcinoma


subject: CHEBI:28911

subject_name: cob(III)alamin

object_name: traumatic encephalopathy


subject: CHEBI:28911

object_name: traumatic brain injury


subject: PUBCHEM.COMPOUND:165339223

subject_name: Vitamin B 12


subject: PUBCHEM.COMPOUND:165339223


subject: HMDB:HMDB0000607

subject_name: Cyanocobalamin


subject: HMDB:HMDB0000607


subject: CHEBI:176843

subject_name: vitamin B12


subject: CHEBI:176843


subject: UMLS:C0086024

subject_name: cobalamins


subject: UMLS:C0086024


subject: CHEBI:17439


subject: CHEBI:17439


subject: UMLS:C2936883

subject_name: Vitamin B12 [EPC]


subject: UMLS:C2936883


subject: CHEBI:176839

subject_name: vitamin B3


subject: CHEBI:176839


subject: CHEBI:15940

subject_name: Niacin


subject: CHEBI:15940


subject: CHEBI:17154

subject_name: Nicotinamide


subject: CHEBI:17154


subject: CHEBI:233362

subject_name: Abemaciclib

object_name: head and neck neoplasm


subject: CHEBI:233362

object_name: head and neck squamous cell carcinoma


subject: CHEBI:16349

subject_name: Citrulline

object_name: cancer


subject: CHEBI:16349

object_name: neoplasm


subject: CHEBI:90942

subject_name: Ixazomib

object_name: lupus nephritis


subject: CHEBI:31898

subject_name: Nedaplatin

object_name: squamous cell carcinoma


subject: CHEMBL.COMPOUND:CHEMBL3137685

subject_name: NEDAPLATIN


subject: CHEMBL.COMPOUND:CHEMBL2108893

subject_name: ALFIMEPRASE

object_name: peripheral vascular disease


subject: CHEMBL.COMPOUND:CHEMBL2108893

object_name: Blood Clot


subject: CHEMBL.COMPOUND:CHEMBL2108893

object_name: thrombosis


subject: CHEMBL.COMPOUND:CHEMBL2108893

object_name: Thrombosis of blood vessel


subject: UMLS:C1097921

subject_name: alfimeprase


subject: UMLS:C1097921


subject: UMLS:C1097921


subject: UMLS:C1097921


subject: CHEBI:3770

subject_name: co-trimoxazole

object_name: vesicoureteral reflux


subject: CHEBI:3770

object_name: vesicoureteral reflux 1


subject: CHEBI:3770

object_name: urinary tract infection


subject: CHEBI:3770

object_name: Recurrent urinary tract infections


subject: UMLS:C0041044


subject: UMLS:C0041044


subject: UMLS:C0041044


subject: UMLS:C0041044


subject: MESH:C581039

object_name: essential thrombocythemia


subject: MESH:C581039

object_name: myelofibrosis


subject: MESH:C581039

object_name: acquired polycythemia vera


subject: UMLS:C2826078

subject_name: Coagadex

object_name: congenital factor X deficiency


subject: UMLS:C2826078

object_name: factor X deficiency


subject: CHEBI:136007

subject_name: methylnaltrexone

object_name: Constipation


subject: CHEBI:136007

object_name: Constipation, CTCAE


subject: CHEBI:33375

subject_name: Gadolinium

object_name: Meniere disease


subject: CHEMBL.COMPOUND:CHEMBL1232993

subject_name: GADOLINIUM


subject: UMLS:C0021755

object_name: adult lymphoma


subject: UMLS:C0021755

object_name: lymphoma


subject: UMLS:C0021755

object_name: pediatric lymphoma


subject: UMLS:C0021755

object_name: neoplasm of testis


subject: UMLS:C0021755

object_name: testicular cancer


subject: UMLS:C0021755

object_name: Neoplasm Metastasis


subject: UMLS:C0021755

object_name: breast neoplasm


subject: CHEBI:66903

subject_name: Vismodegib

object_name: Recurrent Childhood Medulloblastoma


subject: CHEBI:2611

subject_name: Alprazolam

object_name: anxiety disorder


subject: CHEBI:149504

object_name: pancreatic neoplasm


subject: CHEBI:149504

object_name: exocrine pancreatic carcinoma


subject: CHEBI:149504

object_name: malignant pancreatic neoplasm


subject: CHEBI:6541

subject_name: Losartan


subject: CHEBI:6541


subject: CHEBI:6541


subject: CHEBI:5801

subject_name: Hydroxychloroquine

object_name: temporal arteritis


subject: UNII:GKF8S4C432

subject_name: Anlotinib

object_name: Advanced Esophageal Squamous Cell Carcinoma


subject: GTOPDB:12347

subject_name: penpulimab


subject: CHEMBL.COMPOUND:CHEMBL4297571

subject_name: PENPULIMAB


subject: UMLS:C4723695


subject: CHEBI:6741

subject_name: Meloxicam

object_name: osteoarthritis


subject: UMLS:C5706474

subject_name: Anti-TIGIT/Anti-PD-L1 Bispecific Antibody HB0036

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C5706474

object_name: non-small cell lung carcinoma


subject: CHEMBL.COMPOUND:CHEMBL2108334

subject_name: Coagulation factor VIIa Recombinant Human

object_name: Fused vertebrae


subject: UMLS:C0593103

subject_name: Novoseven


subject: PR:000007301

subject_name: coagulation factor VII


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UNII:71M78END5S

subject_name: OMEGA-3 FATTY ACIDS

object_name: Bone fracture


subject: UNII:71M78END5S

object_name: Fractured


subject: CHEBI:25681

subject_name: Omega-3 fatty acids


subject: CHEBI:25681


subject: CHEMBL.COMPOUND:CHEMBL3833369

subject_name: FISH OIL


subject: CHEMBL.COMPOUND:CHEMBL3833369


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina


subject: PUBCHEM.COMPOUND:2735


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: PUBCHEM.COMPOUND:10883523


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: UMLS:C3495434

subject_name: hydroxyethyl starch 130-0.4


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: osteoarthritis, knee


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Agitation, CTCAE 3.0


subject: CHEBI:4466

object_name: Agitation


subject: CHEBI:4466

object_name: Agitation, CTCAE 5.0


subject: CHEBI:4466

object_name: traumatic encephalopathy


subject: CHEBI:4466

object_name: traumatic brain injury


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UNII:7N8K34P2XH


subject: UNII:7N8K34P2XH


subject: UNII:7N8K34P2XH


subject: UNII:7N8K34P2XH


subject: UMLS:C0729210

subject_name: Isovue

object_name: hypothyroidism


subject: UMLS:C0729210

object_name: Hypothyroidism, CTCAE


subject: CHEMBL.COMPOUND:CHEMBL3545073

object_name: ocular hypertension


subject: CHEMBL.COMPOUND:CHEMBL3545073

object_name: Ocular hypertension


subject: CHEMBL.COMPOUND:CHEMBL3545073

object_name: eye disorder


subject: CHEMBL.COMPOUND:CHEMBL3545073

object_name: glaucoma


subject: CHEMBL.COMPOUND:CHEMBL3545073

object_name: Glaucoma, CTCAE


subject: UNII:DTI67O9503

subject_name: Alglucosidase alfa

object_name: Pompe's disease adult onset


subject: UNII:DTI67O9503

object_name: glycogen storage disease due to acid maltase deficiency, late-onset


subject: UNII:DTI67O9503

object_name: glycogen storage disease II


subject: CHEBI:84094

subject_name: testosterone sulfate

object_name: type 2 diabetes mellitus


subject: CHEBI:84094

object_name: Diabetes


subject: CHEBI:84094

object_name: diabetes mellitus


subject: UMLS:C4721537

subject_name: Therapeutic Testosterone


subject: UMLS:C4721537


subject: UMLS:C4721537


subject: UMLS:C4721537

object_name: hypogonadism


subject: CHEBI:17347

subject_name: Testosterone


subject: CHEBI:17347


subject: CHEBI:17347


subject: UMLS:C5554545

subject_name: ERK1/2 Inhibitor ERAS-007

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C5554545

object_name: acute myeloid leukemia


subject: UMLS:C5447494

subject_name: SHP2 Inhibitor ERAS-601


subject: UMLS:C5447494


subject: CHEBI:64312

subject_name: Memantine

object_name: nicotine dependence


subject: CHEBI:2453

subject_name: Acyclovir

object_name: HIV infection


subject: PUBCHEM.COMPOUND:64987

object_name: adult lymphoma


subject: PUBCHEM.COMPOUND:64987

object_name: lymphoma


subject: PUBCHEM.COMPOUND:64987

object_name: pediatric lymphoma


subject: CHEBI:63717

subject_name: Tenofovir disoproxil


subject: CHEBI:63717


subject: CHEBI:63717


subject: CHEBI:63625

subject_name: Tenofovir


subject: CHEBI:63625


subject: CHEBI:63625


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: adrenocortical insufficiency


subject: CHEBI:41879

object_name: Adrenal Insufficiency, CTCAE


subject: CHEBI:4708

subject_name: Doxazosin

object_name: benign prostatic hyperplasia


subject: CHEBI:4708

object_name: Urinary Urgency


subject: UMLS:C2703095

object_name: Childhood Breast Carcinoma


subject: UMLS:C2703095

object_name: breast carcinoma


subject: UMLS:C2703095

object_name: breast cancer


subject: CHEBI:75998

subject_name: Trametinib


subject: CHEBI:75998


subject: CHEBI:75998


subject: CHEBI:2549

subject_name: Albuterol

object_name: Transitory tachypnea of newborn


subject: CHEBI:94518

subject_name: Tranexamic acid

object_name: Placenta Previa


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Respiratory morbidity


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: CHEBI:41423

subject_name: Celecoxib

object_name: osteoarthritis


subject: CHEBI:41423

object_name: rheumatoid arthritis


subject: UMLS:C3819106

subject_name: Pedia-Lax Probiotic

object_name: pervasive developmental disorder


subject: UMLS:C3819106

object_name: autism


subject: UMLS:C3819106

object_name: autism spectrum disorder


subject: CHEBI:23965

subject_name: estradiol


subject: CHEBI:23965


subject: CHEBI:23965


subject: CHEBI:231679

subject_name: ipilimumab

object_name: adult hepatocellular carcinoma


subject: CHEBI:231679

object_name: pediatric hepatocellular carcinoma


subject: CHEBI:231679

object_name: Advanced Hepatocellular Carcinoma


subject: CHEBI:231679

object_name: Metastatic hepatocellular carcinoma


subject: CHEBI:231679

object_name: Unresectable Hepatocellular Carcinoma


subject: CHEBI:231679

object_name: liver neoplasm


subject: UMLS:C5203412

subject_name: Midazolam Liquid Injection

object_name: Pediatric Obesity


subject: UMLS:C5203412

object_name: metabolic dysfunction-associated steatotic liver disease


subject: UMLS:C5203412

object_name: Heartburn


subject: CHEBI:6931

subject_name: Midazolam


subject: CHEBI:6931


subject: CHEBI:6931


subject: CHEBI:7915

subject_name: Pantoprazole


subject: CHEBI:7915


subject: UMLS:C4309517

object_name: malignant soft tissue neoplasm


subject: UMLS:C4309517

object_name: sarcoma


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin

object_name: Carcinoma breast stage IV


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: CHEBI:31348

subject_name: Capecitabine

object_name: Metastatic malignant neoplasm to liver


subject: CHEBI:231601

subject_name: trastuzumab


subject: UNII:SE2KH7T06F


subject: UMLS:C0338204

subject_name: Herceptin


subject: CHEBI:68579

subject_name: Rivaroxaban

object_name: Venous thrombosis after immobility


subject: CHEBI:61272

subject_name: scopolamine hydrobromide trihydrate

object_name: organophosphate poisoning


subject: UMLS:C4518414

subject_name: Scopolamine hydrobromide trihydrate


subject: CHEBI:91541


subject: CHEBI:72690

subject_name: Pomalidomide

object_name: acute myeloid leukemia by FAB classification


subject: CHEBI:72690

object_name: acute myeloid leukemia


subject: CHEBI:72690

object_name: Myelodysplasia


subject: CHEBI:72690

object_name: Adult Myelodysplastic Syndrome


subject: CHEBI:72690

object_name: childhood myelodysplastic syndrome


subject: CHEBI:72690

object_name: Myelodysplastic Syndrome, CTCAE


subject: CHEBI:72690

object_name: acute myeloid leukemia with multilineage dysplasia


subject: CHEBI:72690

object_name: Treatment related acute myeloid leukaemia


subject: CHEBI:72690

object_name: juvenile myelomonocytic leukemia


subject: CHEBI:72690

object_name: chronic myelomonocytic leukemia


subject: CHEBI:72690

object_name: myeloproliferative neoplasm


subject: CHEBI:72690

object_name: Malignant myeloproliferative neoplasm


subject: CHEBI:4653

subject_name: Dipyridamole

object_name: vascular complications


subject: CHEBI:4653

object_name: Pneumonia caused by SARS-CoV-2


subject: CHEBI:27594

subject_name: Graphite

object_name: Heartburn


subject: CHEBI:76842

object_name: sclerosing cholangitis


subject: CHEBI:76842

object_name: primary sclerosing cholangitis


subject: CHEBI:28001

subject_name: Vancomycin


subject: CHEBI:28001


subject: CHEBI:68554

subject_name: Deferiprone

object_name: Parkinson disease


subject: UMLS:C5700412

subject_name: Tavo

object_name: melanoma


subject: UMLS:C3896935

subject_name: c11-1F4 mAb

object_name: plasma cell myeloma


subject: UMLS:C3896935

object_name: AL amyloidosis


subject: UNII:4Z63YK6E0E

subject_name: Daratumumab


subject: PR:000017019

subject_name: UBX domain-containing protein 11


subject: PR:000017019


subject: CHEBI:5523

subject_name: Goserelin

object_name: Carcinoma breast stage IV


subject: UMLS:C0149473

subject_name: Zoladex


subject: CHEBI:94518

subject_name: Tranexamic acid

object_name: Colon Neoplasm


subject: CHEBI:94518

object_name: benign colon neoplasm


subject: DRUGBANK:DB15806

subject_name: CoronaVac


subject: UNII:5085ZFP6SJ

subject_name: TOZINAMERAN


subject: UNII:JSV288Q5CV

subject_name: Famtozinameran


subject: CHEBI:83766

subject_name: Olaparib

object_name: small cell lung carcinoma


subject: CHEBI:6121

subject_name: Ketamine

object_name: renal transplant donor of left kidney


subject: CHEBI:143719

subject_name: H. influenzae type B capsular polysaccharide

object_name: hepatitis B


subject: UMLS:C0032375

subject_name: Oral Poliovirus Vaccine

object_name: poliomyelitis


subject: UMLS:C0032375


subject: UMLS:C0032375

object_name: diphtheria


subject: UMLS:C0032375

object_name: tetanus


subject: CHEBI:31355

subject_name: Carboplatin

object_name: Childhood Neuroblastoma


subject: CHEBI:31355

object_name: neuroblastoma


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:4911


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: UNII:PVI5M0M1GW


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PR:000005932


subject: CHEBI:31824

subject_name: Mesna


subject: CHEBI:31824


subject: CHEBI:17905

subject_name: Coenzyme M


subject: CHEBI:17905


subject: UNII:T5IRO3534A

subject_name: Oncovin


subject: UNII:T5IRO3534A


subject: PUBCHEM.COMPOUND:3717450

subject_name: Leurocristine


subject: PUBCHEM.COMPOUND:3717450


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:28445


subject: CHEBI:38545

subject_name: Rosuvastatin

object_name: chronic obstructive pulmonary disease


subject: CHEBI:33569

subject_name: noradrenaline

object_name: hypotension


subject: CHEBI:33569

object_name: Hypotension, CTCAE


subject: CHEBI:18357

subject_name: Norepinephrine


subject: CHEBI:18357


subject: CHEBI:26710

subject_name: Sodium chloride


subject: CHEBI:26710


subject: CHEBI:135905

subject_name: Terlipressin


subject: CHEBI:135905


subject: CHEBI:4672

subject_name: Docetaxel

object_name: biliary tract cancer


subject: CHEBI:4672

object_name: liver carcinoma


subject: CHEBI:9130

subject_name: Sevoflurane

object_name: Temperature regulation disorder


subject: CHEBI:135192

subject_name: Chlorproguanil

object_name: malaria


subject: CHEBI:4325

subject_name: Dapsone


subject: CHEBI:9329

subject_name: Sulfadoxine


subject: CHEBI:8673

subject_name: Pyrimethamine


subject: UNII:79R3ZF226Y

object_name: colon carcinoma


subject: UNII:79R3ZF226Y

object_name: colorectal cancer


subject: UNII:79R3ZF226Y

object_name: colon cancer


subject: CHEBI:53228


subject: CHEBI:53228


subject: CHEBI:53228


subject: CHEBI:60622


subject: CHEBI:60622


subject: CHEBI:60622


subject: CHEBI:3374

subject_name: Capsaicin

object_name: Peripheral neuropathy due to and following antineoplastic therapy


subject: PUBCHEM.COMPOUND:138376495

subject_name: Cefiderocol

object_name: Sepsis


subject: CHEBI:94366

subject_name: itraconazole

object_name: acute myeloid leukemia by FAB classification


subject: CHEBI:94366

object_name: acute myeloid leukemia


subject: CHEBI:94366

object_name: acute lymphoblastic leukemia


subject: CHEBI:94366

object_name: acute leukemia of ambiguous lineage


subject: CHEBI:94366

object_name: acute biphenotypic leukemia


subject: CHEBI:94366

object_name: mixed phenotype acute leukemia


subject: CHEBI:94366

object_name: Advanced cancer


subject: CHEBI:6931

subject_name: Midazolam


subject: CHEBI:6931


subject: CHEBI:6931


subject: CHEBI:6931


subject: CHEBI:6931


subject: CHEBI:6931


subject: CHEBI:6931


subject: UNII:4MOD1F4ENC

subject_name: Ziftomenib


subject: UNII:4MOD1F4ENC


subject: UNII:4MOD1F4ENC


subject: UNII:4MOD1F4ENC


subject: UNII:4MOD1F4ENC


subject: CHEMBL.COMPOUND:CHEMBL2108758

subject_name: PEPPERMINT OIL

object_name: Abdominal pain


subject: CHEMBL.COMPOUND:CHEMBL2108758

object_name: Abdominal Pain, CTCAE


subject: CHEBI:15365

subject_name: Aspirin

object_name: Blood Clot


subject: CHEBI:15365

object_name: thrombosis


subject: CHEBI:15365

object_name: Thrombosis of blood vessel


subject: CHEBI:601027

subject_name: Aliskiren

object_name: diabetes mellitus


subject: CHEBI:5778

subject_name: Hydrochlorothiazide


subject: CHEBI:94534

subject_name: olanzapine

object_name: Opioid Misuse


subject: CHEBI:188637

subject_name: Evacetrapib

object_name: Hypercholesterolemia


subject: UNII:51XWV9K850


subject: CHEBI:231324

subject_name: alpelisib

object_name: type 2 diabetes mellitus


subject: CHEBI:231324

object_name: Insulin resistance


subject: CHEBI:231324

object_name: hyperinsulinism


subject: CHEBI:231324

object_name: Hyperinsulinemia


subject: CHEBI:231324

object_name: Dyslipidemia


subject: CHEBI:66910

subject_name: Axitinib

object_name: nonpapillary renal cell carcinoma


subject: CHEBI:66910

object_name: clear cell renal carcinoma


subject: CHEBI:66910

object_name: renal cell adenocarcinoma


subject: CHEBI:2668

subject_name: Amlodipine

object_name: hypertension, pregnancy-induced


subject: CHEBI:2668

object_name: Maternal hypertension


subject: CHEBI:291342

subject_name: Desloratadine

object_name: chronic urticaria


subject: CHEBI:31401

subject_name: Cilostazol


subject: CHEBI:4653

subject_name: Dipyridamole


subject: CHEBI:31355

subject_name: Carboplatin

object_name: glioma susceptibility 1


subject: CHEBI:31355

object_name: ependymoma


subject: CHEBI:31355

object_name: childhood ependymoma


subject: CHEBI:31355

object_name: Newly Diagnosed Childhood Ependymoma


subject: CHEBI:31355

object_name: Adult Ependymoma


subject: CHEBI:31355

object_name: Brain Ependymoma


subject: CHEBI:31355

object_name: adult brain ependymoma


subject: CHEBI:31355

object_name: ependymal tumor of brain


subject: CHEBI:31355

object_name: clear cell ependymoma


subject: CHEBI:31355

object_name: cellular ependymoma


subject: CHEBI:31355

object_name: papillary ependymoma


subject: CHEBI:31355

object_name: anaplastic ependymoma


subject: CHEBI:31355

object_name: adult anaplastic ependymoma


subject: CHEBI:31355

object_name: Childhood Anaplastic Ependymoma


subject: CHEBI:132922

object_name: Premature infant


subject: CHEBI:132922

object_name: patent ductus arteriosus


subject: CHEBI:43415

subject_name: Dexibuprofen


subject: CHEBI:43415


subject: CHEBI:5855

subject_name: Ibuprofen


subject: CHEBI:5855


subject: CHEBI:31355

object_name: Carcinoma of peritoneum


subject: UMLS:C4053607

object_name: liver carcinoma


subject: UMLS:C4085945

object_name: Refractory acute myeloid leukemia


subject: UMLS:C4085945

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C4085945

object_name: acute myeloid leukemia


subject: UMLS:C4085945

object_name: CD4+/CD56+ hematodermic neoplasm


subject: UMLS:C4085945

object_name: Late Relapse of Acute Myeloid Leukemia


subject: UMLS:C4085945

object_name: therapy related acute myeloid leukemia and myelodysplastic syndrome


subject: UMLS:C4085945

object_name: Early Relapse of Acute Myeloid Leukemia


subject: UMLS:C4085945

object_name: recurrent adult acute myeloid leukemia


subject: UMLS:C4085945

object_name: Untreated Adult Acute Myeloid Leukemia


subject: UMLS:C4085945

object_name: Adult Acute Myeloid Leukemia in Remission


subject: UMLS:C4085945

object_name: adult acute lymphoblastic leukemia


subject: UMLS:C4085945

object_name: acute biphenotypic leukemia


subject: UMLS:C4085945

object_name: Infant Acute Biphenotypic Leukemia


subject: UMLS:C4085945

object_name: Interleukin-3 Receptor Subunit Alpha Positive


subject: UMLS:C4085945

object_name: Neoplasm, Residual


subject: PUBCHEM.COMPOUND:3368

subject_name: Fludara


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: UMLS:C1704263

subject_name: green tea extract

object_name: colorectal neoplasm


subject: DRUGBANK:DB14307

subject_name: Green tea leaf


subject: UMLS:C4704216

subject_name: PLUROGEL

object_name: Burn injury


subject: PUBCHEM.COMPOUND:73151030

subject_name: Empagliflozin

object_name: Fatty Liver


subject: PUBCHEM.COMPOUND:73151030


subject: CHEBI:135563

subject_name: elcometrine

object_name: Uses contraception (finding)


subject: CHEBI:4903

subject_name: Ethinylestradiol


subject: UMLS:C5203351

subject_name: Furosemide Liquid Injection

object_name: Fluid Overload


subject: UMLS:C5203351

object_name: Hypervolemia


subject: UMLS:C5203351

object_name: Critical Illness


subject: UMLS:C5203351

object_name: Sepsis


subject: UMLS:C5203351

object_name: Sepsis, CTCAE


subject: UMLS:C5203351

object_name: Physical trauma


subject: UMLS:C5203351

object_name: Injury


subject: UMLS:C5203351

object_name: Trauma


subject: UMLS:C5203351

object_name: familial acute respiratory distress syndrome, ANLN-related, dog


subject: UMLS:C5203351

object_name: acute respiratory distress syndrome


subject: UMLS:C5203351

object_name: COVID-19-Associated Acute Respiratory Distress Syndrome


subject: UMLS:C5203351

object_name: adult acute respiratory distress syndrome


subject: UMLS:C4048177

subject_name: furosemide injection


subject: UMLS:C4048177


subject: UMLS:C4048177


subject: UMLS:C4048177


subject: UMLS:C4048177


subject: UMLS:C4048177


subject: UMLS:C4048177


subject: UMLS:C4048177


subject: UMLS:C4048177


subject: UMLS:C4048177


subject: UMLS:C4048177


subject: UMLS:C4048177


subject: CHEBI:47426

subject_name: Furosemide


subject: CHEBI:47426


subject: CHEBI:47426


subject: CHEBI:47426


subject: CHEBI:47426


subject: CHEBI:47426


subject: CHEBI:47426


subject: CHEBI:47426


subject: CHEBI:47426


subject: CHEBI:47426


subject: CHEBI:47426


subject: CHEBI:47426


subject: CHEBI:64354

subject_name: Metolazone


subject: CHEBI:64354


subject: CHEBI:64354


subject: CHEBI:64354


subject: CHEBI:64354


subject: CHEBI:64354


subject: CHEBI:64354


subject: CHEBI:64354


subject: CHEBI:64354


subject: CHEBI:64354


subject: CHEBI:64354


subject: CHEBI:64354


subject: UMLS:C4725022

subject_name: PKC-beta Inhibitor MS-553

object_name: B-cell chronic lymphocytic leukemia


subject: PUBCHEM.COMPOUND:979735


subject: UNII:8R2YWY4LXF


subject: PR:000008885

subject_name: immature colon carcinoma transcript 1 protein


subject: PUBCHEM.COMPOUND:979718


subject: CHEBI:135530

subject_name: Solifenacin

object_name: multiple sclerosis


subject: CHEBI:135530

object_name: Neurogenic bladder


subject: UNII:8M7V7Q6537

subject_name: Pegunigalsidase alfa

object_name: Fabry disease


subject: UNII:CI43QFE22O

object_name: Adult Soft Tissue Sarcoma


subject: CHEBI:31859

subject_name: Modafinil

object_name: cocaine dependence


subject: GTOPDB:12966

subject_name: cadonilimab

object_name: Stomach cancer


subject: GTOPDB:12966

object_name: gastric cancer


subject: CHEMBL.COMPOUND:CHEMBL4594456

subject_name: CADONILIMAB


subject: CHEMBL.COMPOUND:CHEMBL4594456


subject: UMLS:C4727210

subject_name: Cadonilimab


subject: UMLS:C4727210


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: PUBCHEM.COMPOUND:43805


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UMLS:C1314429


subject: PUBCHEM.COMPOUND:70105374

subject_name: Pitavastatin Lactone

object_name: hyperlipidemia


subject: PUBCHEM.COMPOUND:70105374

object_name: hyperlipoproteinemia


subject: PUBCHEM.COMPOUND:70105374

object_name: Hyperlipidemia, CTCAE


subject: PUBCHEM.COMPOUND:70105374

object_name: Serum lipids high (finding)


subject: PUBCHEM.COMPOUND:70105374

object_name: carotid artery disorder


subject: CHEBI:32020

subject_name: Pitavastatin


subject: CHEBI:32020


subject: CHEBI:32020


subject: CHEBI:32020


subject: CHEBI:32020


subject: PUBCHEM.COMPOUND:521372

subject_name: Cannabidiol

object_name: alcohol abuse


subject: PUBCHEM.COMPOUND:521372

object_name: alcohol dependence


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: Malignant neoplasm of stomach stage IV


subject: UNII:52CMI0WC3Y

object_name: stage IV esophageal cancer


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: CHEBI:8378

subject_name: Prednisolone

object_name: glucose intolerance


subject: CHEBI:8378

object_name: Glucose Intolerance, CTCAE


subject: CHEBI:8378

object_name: type 2 diabetes mellitus


subject: CHEBI:8378

object_name: Insulin resistance


subject: CHEBI:8378

object_name: hyperglycemia


subject: CHEBI:8378

object_name: Hyperglycemia, CTCAE


subject: CHEBI:8378

object_name: Glucose in blood specimen above reference range


subject: UMLS:C0376541

subject_name: Recombinant Erythropoietin

object_name: anemia


subject: UMLS:C0376541

object_name: Anemia, CTCAE


subject: CHEBI:190738

subject_name: Demethylated antipyrine

object_name: optic neuritis


subject: UNII:S798V6YJRP

subject_name: EDARAVONE


subject: CHEBI:31530

subject_name: Edaravone


subject: CHEBI:221840

object_name: Stage II Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:221840

object_name: Pancreatic carcinoma stage II


subject: CHEBI:221840

object_name: Stage II Pancreatic Cancer AJCC v8


subject: CHEBI:221840

object_name: Stage IV Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:221840

object_name: stage IV pancreatic cancer


subject: CHEBI:221840

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: CHEBI:221840

object_name: Pancreatic carcinoma recurrent


subject: CHEBI:221840

object_name: Stage III Pancreatic Cancer AJCC v8


subject: CHEBI:221840

object_name: Pancreatic carcinoma stage III


subject: CHEBI:221840

object_name: Stage III Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:221840

object_name: pancreatic adenocarcinoma


subject: PUBCHEM.COMPOUND:4616292


subject: PUBCHEM.COMPOUND:4616292


subject: PUBCHEM.COMPOUND:4616292


subject: PUBCHEM.COMPOUND:4616292


subject: PUBCHEM.COMPOUND:4616292


subject: PUBCHEM.COMPOUND:4616292


subject: PUBCHEM.COMPOUND:4616292


subject: PUBCHEM.COMPOUND:4616292


subject: PUBCHEM.COMPOUND:4616292


subject: PUBCHEM.COMPOUND:4616292


subject: PUBCHEM.COMPOUND:4616292


subject: UNII:200AW54D93

subject_name: PEMZIVIPTADIL

object_name: acute respiratory distress syndrome


subject: UNII:200AW54D93

object_name: adult acute respiratory distress syndrome


subject: UNII:200AW54D93


subject: UNII:200AW54D93

object_name: respiratory failure


subject: UNII:200AW54D93

object_name: Respiratory Failure, CTCAE


subject: UNII:200AW54D93

object_name: Respiratory complication


subject: UNII:200AW54D93

object_name: bronchopulmonary dysplasia


subject: UNII:200AW54D93

object_name: Respiratory insufficiency


subject: UNII:200AW54D93

object_name: Hypoxic respiratory failure


subject: UNII:200AW54D93

object_name: Hypoxemic Respiratory Failure


subject: UNII:200AW54D93

object_name: pneumonitis


subject: UNII:200AW54D93

object_name: pneumonia


subject: UNII:200AW54D93

object_name: Cardiac complication


subject: UNII:200AW54D93

object_name: Cardiac dysfunction


subject: UNII:200AW54D93

object_name: cytokine release syndrome


subject: UNII:200AW54D93

object_name: Cytokine storm


subject: UNII:200AW54D93

object_name: myocardial infarction


subject: UNII:200AW54D93

object_name: pulmonary edema


subject: UNII:200AW54D93

object_name: Pulmonary Edema, CTCAE


subject: UNII:200AW54D93

object_name: heart failure


subject: UNII:200AW54D93

object_name: Cardiac Events


subject: UNII:200AW54D93

object_name: Coronavinae infectious disease


subject: UNII:200AW54D93

object_name: COVID-19-Associated Pneumonia


subject: UMLS:C5392699

object_name: acute respiratory distress syndrome


subject: UMLS:C5392699

object_name: adult acute respiratory distress syndrome


subject: UMLS:C5392699


subject: UMLS:C5392699

object_name: respiratory failure


subject: UMLS:C5392699

object_name: Respiratory Failure, CTCAE


subject: UMLS:C5392699

object_name: Respiratory complication


subject: UMLS:C5392699

object_name: bronchopulmonary dysplasia


subject: UMLS:C5392699

object_name: Respiratory insufficiency


subject: UMLS:C5392699

object_name: Hypoxic respiratory failure


subject: UMLS:C5392699

object_name: Hypoxemic Respiratory Failure


subject: UMLS:C5392699

object_name: pneumonitis


subject: UMLS:C5392699

object_name: pneumonia


subject: UMLS:C5392699

object_name: Cardiac complication


subject: UMLS:C5392699

object_name: Cardiac dysfunction


subject: UMLS:C5392699

object_name: cytokine release syndrome


subject: UMLS:C5392699

object_name: Cytokine storm


subject: UMLS:C5392699

object_name: myocardial infarction


subject: UMLS:C5392699

object_name: pulmonary edema


subject: UMLS:C5392699

object_name: Pulmonary Edema, CTCAE


subject: UMLS:C5392699

object_name: heart failure


subject: UMLS:C5392699

object_name: Cardiac Events


subject: UMLS:C5392699

object_name: Coronavinae infectious disease


subject: UMLS:C5392699

object_name: COVID-19-Associated Pneumonia


subject: UMLS:C5854509

subject_name: ADC 9MW2821

object_name: Solid Neoplasm


subject: UMLS:C5418001

subject_name: LAIR-2 Fusion Protein NC410

object_name: colorectal carcinoma


subject: UMLS:C5418001

object_name: Stomach cancer


subject: UMLS:C5418001

object_name: gastric cancer


subject: UMLS:C5418001

object_name: ovarian cancer


subject: UMLS:C5418001

object_name: ovarian neoplasm


subject: UMLS:C5418001

object_name: ovarian carcinoma


subject: UMLS:C5417967

subject_name: AR Inhibitor EPI-7386

object_name: prostate carcinoma


subject: UMLS:C5417967

object_name: prostate cancer


subject: CHEBI:50853

subject_name: quantum dot


subject: CHEBI:50853


subject: UNII:2N4O9L084N

subject_name: Nabilone

object_name: primary progressive aphasia


subject: UNII:2N4O9L084N

object_name: Pick Complex


subject: UNII:2N4O9L084N

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: UNII:2N4O9L084N

object_name: frontotemporal dementia


subject: UNII:2N4O9L084N

object_name: Pick disease


subject: UNII:2N4O9L084N

object_name: behavioral variant of frontotemporal dementia


subject: UMLS:C4687411

subject_name: CELMoD CC-92480

object_name: plasma cell myeloma


subject: CHEBI:63589

subject_name: Etravirine

object_name: chronic hepatitis B virus infection


subject: CHEBI:60481


subject: PR:000008953

subject_name: insulin-like growth factor-binding protein 7


subject: UMLS:C5666986

subject_name: NKp46/CD16-based CD123-targeted NK Cell Engager SAR443579

object_name: Blastic plasmacytoid dendritic cell neoplasia


subject: UMLS:C5666986

object_name: Refractory acute myeloid leukemia


subject: UMLS:C5666986

object_name: Myelodysplasia


subject: UMLS:C5666986

object_name: acute lymphoblastic leukemia


subject: UMLS:C4764313

subject_name: Zoster Vaccine Recombinant, Adjuvanted

object_name: inflammatory bowel disease


subject: UMLS:C4764313

object_name: irritable bowel syndrome


subject: UNII:YI437801BE

subject_name: Mogamulizumab

object_name: non-small cell lung carcinoma


subject: UMLS:C1831941


subject: UMLS:C0358855

subject_name: Nicotine Transdermal Patch

object_name: post operative nausea and vomiting


subject: UNII:8K80YB5GMG

subject_name: Rilonacept

object_name: familial Mediterranean fever


subject: UNII:8K80YB5GMG

object_name: autosomal recessive familial Mediterranean fever


subject: UMLS:C2343505

subject_name: Arcalyst


subject: UMLS:C2343505


subject: CHEBI:31355

subject_name: Carboplatin

object_name: peritoneal neoplasm


subject: UNII:PQX0D8J21J

subject_name: Cetuximab

object_name: fallopian tube neoplasm


subject: UNII:PQX0D8J21J


subject: UMLS:C0879636

subject_name: IMC C225


subject: UMLS:C0879636


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:144094

subject_name: bicalutamide

object_name: Prostate cancer recurrent


subject: CHEBI:144094

object_name: prostate adenocarcinoma


subject: CHEBI:5132

subject_name: Flutamide


subject: CHEBI:5132


subject: CHEBI:5523

subject_name: Goserelin


subject: CHEBI:5523


subject: UMLS:C0149473

subject_name: Zoladex


subject: UMLS:C0149473


subject: CHEBI:6427

subject_name: Leuprolide


subject: CHEBI:6427


subject: CHEBI:7573

subject_name: Nilutamide


subject: CHEBI:7573


subject: CHEBI:79699

subject_name: Temsirolimus


subject: CHEBI:79699


subject: CHEBI:51254

subject_name: AMOXICILLIN

object_name: Premature birth


subject: PUBCHEM.COMPOUND:2171


subject: CHEBI:2676

subject_name: Amoxicillin


subject: CHEBI:48923

subject_name: erythromycin


subject: CHEBI:42355

subject_name: Erythromycin


subject: PUBCHEM.COMPOUND:2269


subject: UMLS:C0812732

subject_name: INJECTION, AZITHROMYCIN, 500 MG ADMINISTERED


subject: CHEBI:2955

subject_name: Azithromycin


subject: CHEBI:5864

subject_name: Ifosfamide

object_name: B-cell neoplasm


subject: CHEBI:31355

subject_name: Carboplatin


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED

object_name: brain neoplasm


subject: CHEBI:72564

subject_name: Temozolomide


subject: CHEBI:41774

subject_name: Tamoxifen

object_name: glioblastoma


subject: CHEBI:41774

object_name: Childhood Glioblastoma


subject: CHEBI:41774

object_name: adult glioblastoma


subject: CHEBI:41774


subject: CHEBI:6690

subject_name: Maprotiline


subject: CHEBI:6690


subject: CHEBI:6690


subject: CHEBI:6690


subject: UMLS:C0301532

subject_name: Multivitamin preparation

object_name: Stress


subject: PUBCHEM.COMPOUND:76470875

subject_name: Glecaprevir

object_name: kidney failure


subject: PUBCHEM.COMPOUND:76470875

object_name: chronic kidney disease


subject: PUBCHEM.COMPOUND:76668718

subject_name: Pibrentasvir


subject: PUBCHEM.COMPOUND:76668718


subject: CHEBI:36796

subject_name: duloxetine

object_name: neuralgia


subject: CHEBI:36796

object_name: Neuropathic pain


subject: UNII:GN465U8B72

subject_name: Nemolizumab

object_name: systemic sclerosis


subject: CHEBI:5001

subject_name: Fenofibrate

object_name: diabetic retinopathy


subject: CHEBI:5001

object_name: type 1 diabetes mellitus 1


subject: CHEBI:5001

object_name: type 1 diabetes mellitus


subject: CHEBI:5001

object_name: diabetic kidney disease


subject: CHEBI:60789

subject_name: bupivacaine hydrochloride hydrate

object_name: neuropathy


subject: CHEBI:3215

subject_name: Bupivacaine


subject: CHEBI:6888

subject_name: Methylprednisolone


subject: UMLS:C3540792

subject_name: Magnesium supplements, alimentary tract and metabolism


subject: CHEBI:25107

subject_name: magnesium atom


subject: CHEBI:18420


subject: UMLS:C3714621

subject_name: Magnesium Drug Class


subject: UMLS:C0445115

subject_name: Normal saline


subject: GTOPDB:4968

subject_name: IFN-γ

object_name: colorectal cancer


subject: GTOPDB:4968

object_name: colorectal carcinoma


subject: GTOPDB:4968

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:73579

subject_name: Leu-Val


subject: CHEBI:73579


subject: CHEBI:73579


subject: CHEBI:194537

subject_name: Livermorium


subject: CHEBI:194537


subject: CHEBI:194537


subject: UMLS:C1881413

subject_name: Liposome Vesicle


subject: UMLS:C1881413


subject: UMLS:C1881413


subject: PR:000003915

subject_name: delta-aminolevulinic acid dehydratase


subject: PR:000003915


subject: PR:000003915


subject: CHEBI:74557

subject_name: Lys-Glu

object_name: Alzheimer disease type 1


subject: CHEBI:74557

object_name: Alzheimer disease


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: EXCESS LMW-DNA


subject: PUBCHEM.COMPOUND:1972

subject_name: Fungizone

object_name: Kala-Azar


subject: CHEBI:2682

subject_name: Amphotericin B


subject: CHEBI:75283

subject_name: Miltefosine


subject: PUBCHEM.COMPOUND:4689

subject_name: Paromomycin I


subject: CHEBI:233202


subject: CHEBI:7934

subject_name: Paromomycin


subject: UNII:M89N0Q7EQR

subject_name: Aldesleukin

object_name: Melanoma recurrent


subject: UNII:M89N0Q7EQR

object_name: Stage III Cutaneous Melanoma AJCC v7


subject: UNII:M89N0Q7EQR

object_name: Stage IIIC Cutaneous Melanoma AJCC v7


subject: UNII:M89N0Q7EQR

object_name: Stage IIIB Cutaneous Melanoma AJCC v7


subject: UNII:M89N0Q7EQR

object_name: Stage IIIA Cutaneous Melanoma AJCC v7


subject: UNII:M89N0Q7EQR

object_name: Stage IV Cutaneous Melanoma AJCC v6 and v7


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: UNII:15C2VL427D

subject_name: Aflibercept


subject: UNII:15C2VL427D

object_name: metastatic melanoma


subject: UNII:15C2VL427D


subject: UNII:15C2VL427D


subject: UNII:15C2VL427D


subject: UNII:15C2VL427D


subject: UNII:15C2VL427D


subject: UniProtKB:Q05920

subject_name: PYC_MOUSE Pyruvate carboxylase, mitochondrial (sprot)

object_name: acute myocardial infarction


subject: UniProtKB:Q05920

object_name: Acute Myocardial Infarction by ECG Finding


subject: PUBCHEM.COMPOUND:9821941

subject_name: lumateperone

object_name: endogenous depression


subject: PUBCHEM.COMPOUND:9821941

object_name: major depressive disorder


subject: CHEBI:94807

subject_name: Nitazoxanide


subject: PUBCHEM.COMPOUND:50587

subject_name: THYMOPENTIN

object_name: HIV infection


subject: CHEBI:26710

subject_name: Sodium chloride

object_name: influenza


subject: UMLS:C0728976

subject_name: Control brand of phenylpropanolamine

object_name: Photoallergy


subject: UMLS:C0308718

subject_name: CONTROL veterinary product


subject: UMLS:C1550141

subject_name: control substance


subject: UMLS:C5198720

object_name: type 2 diabetes mellitus


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: nasopharyngeal carcinoma


subject: UNII:DPT0O3T46P

object_name: nasopharyngeal carcinoma, susceptibility to, 1


subject: UNII:DPT0O3T46P

object_name: malignant tumor of nasopharynx


subject: UNII:DPT0O3T46P

object_name: adult hepatocellular carcinoma


subject: UNII:DPT0O3T46P

object_name: pediatric hepatocellular carcinoma


subject: UNII:DPT0O3T46P

object_name: Mesothelioma


subject: UNII:DPT0O3T46P

object_name: mesothelial neoplasm


subject: UMLS:C5666946

subject_name: Antibody STING Drug Conjugate TAK-500

object_name: pancreatic neoplasm


subject: UMLS:C5666946

object_name: exocrine pancreatic carcinoma


subject: UMLS:C5666946

object_name: malignant pancreatic neoplasm


subject: UMLS:C5666946


subject: UMLS:C5666946


subject: UMLS:C5666946


subject: UMLS:C5666946


subject: UMLS:C5666946

object_name: liver cancer


subject: UMLS:C5666946


subject: UMLS:C5666946

object_name: liver carcinoma


subject: UMLS:C5666946

object_name: carcinoma of esophagus


subject: UMLS:C5666946

object_name: esophageal cancer


subject: UMLS:C5666946

object_name: Childhood Esophageal Carcinoma


subject: UMLS:C5666946

object_name: neoplasm of esophagus


subject: UMLS:C5666946

object_name: Stomach cancer


subject: UMLS:C5666946

object_name: gastric cancer


subject: UMLS:C5666946

object_name: Childhood Breast Carcinoma


subject: UMLS:C5666946

object_name: breast carcinoma


subject: UMLS:C5666946

object_name: breast cancer


subject: UMLS:C5666946

object_name: renal carcinoma


subject: UMLS:C5666946

object_name: kidney neoplasm


subject: UMLS:C5666946

object_name: kidney cancer


subject: UMLS:C5666946

object_name: Mesothelioma


subject: UMLS:C5666946

object_name: mesothelial neoplasm


subject: UMLS:C5666946

object_name: malignant mesothelioma


subject: CHEBI:37563

object_name: Skin Wrinkling


subject: CHEBI:37563

object_name: Skin Manifestations


subject: CHEBI:17677

subject_name: CTP


subject: CHEBI:17677


subject: UMLS:C4554189


subject: UMLS:C4554189


subject: PR:000015004

subject_name: tricarboxylate transport protein, mitochondrial


subject: PR:000015004


subject: UMLS:C1292474

subject_name: Catheter tip specimen


subject: UMLS:C1292474


subject: CHEBI:64816

object_name: malignant soft tissue neoplasm


subject: CHEBI:91872


subject: UNII:R581OT55EA

subject_name: PEG-uricase

object_name: gout


subject: PUBCHEM.COMPOUND:71226663

subject_name: Acalabrutinib

object_name: non-small cell lung carcinoma


subject: PUBCHEM.COMPOUND:71226663

object_name: marginal zone lymphoma


subject: PUBCHEM.COMPOUND:71226663

object_name: MALT lymphoma


subject: CHEBI:30430

subject_name: indium atom

object_name: overdose


subject: CHEBI:74063

subject_name: Ile-Asn


subject: CHEBI:30429

subject_name: Indium


subject: CHEBI:7459

subject_name: Naloxone


subject: PUBCHEM.COMPOUND:46874763

object_name: acute myeloid leukemia by FAB classification


subject: PUBCHEM.COMPOUND:46874763

object_name: acute myeloid leukemia


subject: UniProtKB:P19726

subject_name: CAPSA_BPT7 Major capsid protein (sprot)


subject: UniProtKB:P19726


subject: UMLS:C4744797

subject_name: Darzalex Faspro

object_name: Bone marrow transplant rejection


subject: UMLS:C4744797

object_name: pulmonary fibrosis and/or bone marrow failure, Telomere-related, 2


subject: UMLS:C4744797

object_name: aplastic anemia


subject: UMLS:C4744797

object_name: idiopathic aplastic anemia


subject: UMLS:C4744797

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: UMLS:C4744797

object_name: adult acute myeloid leukemia


subject: UMLS:C4744797

object_name: childhood acute myeloid leukemia


subject: UMLS:C4744797


subject: UMLS:C4744797

object_name: hematopoietic and lymphoid cell neoplasm


subject: UMLS:C4744797

object_name: hematopoietic and lymphoid system neoplasm


subject: UMLS:C4744797

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: UMLS:C4744797

object_name: non-Hodgkin lymphoma


subject: UMLS:C4744797

object_name: plasma cell myeloma


subject: UMLS:C4744797

object_name: Hodgkin Disease


subject: UMLS:C4744797

object_name: Adult Hodgkin Lymphoma


subject: UMLS:C4744797

object_name: Childhood Hodgkin Lymphoma


subject: UMLS:C4744797

object_name: myelofibrosis


subject: UMLS:C4744797

object_name: adult lymphoma


subject: UMLS:C4744797

object_name: lymphoma


subject: UMLS:C4744797

object_name: pediatric lymphoma


subject: UNII:4Z63YK6E0E

subject_name: Daratumumab

object_name: Bone marrow transplant rejection


subject: UNII:4Z63YK6E0E

object_name: pulmonary fibrosis and/or bone marrow failure, Telomere-related, 2


subject: UNII:4Z63YK6E0E

object_name: aplastic anemia


subject: UNII:4Z63YK6E0E

object_name: idiopathic aplastic anemia


subject: UNII:4Z63YK6E0E

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: UNII:4Z63YK6E0E

object_name: adult acute myeloid leukemia


subject: UNII:4Z63YK6E0E

object_name: childhood acute myeloid leukemia


subject: UNII:4Z63YK6E0E

object_name: acute myeloid leukemia


subject: UNII:4Z63YK6E0E

object_name: hematopoietic and lymphoid cell neoplasm


subject: UNII:4Z63YK6E0E

object_name: hematopoietic and lymphoid system neoplasm


subject: UNII:4Z63YK6E0E

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: UNII:4Z63YK6E0E

object_name: non-Hodgkin lymphoma


subject: UNII:4Z63YK6E0E

object_name: Hodgkin Disease


subject: UNII:4Z63YK6E0E

object_name: Adult Hodgkin Lymphoma


subject: UNII:4Z63YK6E0E

object_name: Childhood Hodgkin Lymphoma


subject: UNII:4Z63YK6E0E

object_name: myelofibrosis


subject: UNII:4Z63YK6E0E

object_name: adult lymphoma


subject: UNII:4Z63YK6E0E

object_name: lymphoma


subject: UNII:4Z63YK6E0E

object_name: pediatric lymphoma


subject: PUBCHEM.COMPOUND:91820602

subject_name: Hyaluronidase

object_name: Bone marrow transplant rejection


subject: PUBCHEM.COMPOUND:91820602

object_name: pulmonary fibrosis and/or bone marrow failure, Telomere-related, 2


subject: PUBCHEM.COMPOUND:91820602

object_name: aplastic anemia


subject: PUBCHEM.COMPOUND:91820602

object_name: idiopathic aplastic anemia


subject: PUBCHEM.COMPOUND:91820602

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: PUBCHEM.COMPOUND:91820602

object_name: adult acute myeloid leukemia


subject: PUBCHEM.COMPOUND:91820602

object_name: childhood acute myeloid leukemia


subject: PUBCHEM.COMPOUND:91820602

object_name: acute myeloid leukemia


subject: PUBCHEM.COMPOUND:91820602

object_name: hematopoietic and lymphoid cell neoplasm


subject: PUBCHEM.COMPOUND:91820602

object_name: hematopoietic and lymphoid system neoplasm


subject: PUBCHEM.COMPOUND:91820602

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: PUBCHEM.COMPOUND:91820602

object_name: non-Hodgkin lymphoma


subject: PUBCHEM.COMPOUND:91820602

object_name: plasma cell myeloma


subject: PUBCHEM.COMPOUND:91820602

object_name: Hodgkin Disease


subject: PUBCHEM.COMPOUND:91820602

object_name: Adult Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:91820602

object_name: Childhood Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:91820602

object_name: myelofibrosis


subject: PUBCHEM.COMPOUND:91820602

object_name: adult lymphoma


subject: PUBCHEM.COMPOUND:91820602

object_name: lymphoma


subject: PUBCHEM.COMPOUND:91820602

object_name: pediatric lymphoma


subject: UMLS:C5383290

subject_name: hyaluronidase-fihj

object_name: Bone marrow transplant rejection


subject: UMLS:C5383290

object_name: pulmonary fibrosis and/or bone marrow failure, Telomere-related, 2


subject: UMLS:C5383290

object_name: aplastic anemia


subject: UMLS:C5383290

object_name: idiopathic aplastic anemia


subject: UMLS:C5383290

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: UMLS:C5383290

object_name: adult acute myeloid leukemia


subject: UMLS:C5383290

object_name: childhood acute myeloid leukemia


subject: UMLS:C5383290

object_name: acute myeloid leukemia


subject: UMLS:C5383290

object_name: hematopoietic and lymphoid cell neoplasm


subject: UMLS:C5383290

object_name: hematopoietic and lymphoid system neoplasm


subject: UMLS:C5383290

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: UMLS:C5383290

object_name: non-Hodgkin lymphoma


subject: UMLS:C5383290

object_name: plasma cell myeloma


subject: UMLS:C5383290

object_name: Hodgkin Disease


subject: UMLS:C5383290

object_name: Adult Hodgkin Lymphoma


subject: UMLS:C5383290

object_name: Childhood Hodgkin Lymphoma


subject: UMLS:C5383290

object_name: myelofibrosis


subject: UMLS:C5383290

object_name: adult lymphoma


subject: UMLS:C5383290

object_name: lymphoma


subject: UMLS:C5383290

object_name: pediatric lymphoma


subject: CHEBI:4975

subject_name: Famotidine

object_name: Heartburn


subject: CHEBI:233362

subject_name: Abemaciclib

object_name: Metastatic Colorectal Carcinoma


subject: CHEBI:233362

object_name: Unresectable Colorectal Carcinoma


subject: CHEBI:233362

object_name: Stage IIIC Colorectal Cancer AJCC v8


subject: CHEBI:233362

object_name: Stage IVC Colorectal Cancer AJCC v8


subject: CHEBI:233362

object_name: Stage IV Colorectal Cancer AJCC v8


subject: CHEBI:233362

object_name: Stage IVA Colorectal Cancer AJCC v8


subject: CHEBI:233362

object_name: Stage III Colorectal Cancer AJCC v8


subject: CHEBI:233362

object_name: Stage IVB Colorectal Cancer AJCC v8


subject: CHEBI:233362

object_name: Stage IIIB Colorectal Cancer AJCC v8


subject: CHEBI:233362

object_name: Stage IIIA Colorectal Cancer AJCC v8


subject: CHEBI:233362

object_name: Unresectable Rectal Adenocarcinoma


subject: CHEBI:233362

object_name: Adenocarcinoma of colon metastatic


subject: CHEBI:233362

object_name: Stage IV Rectal Cancer AJCC v8


subject: CHEBI:233362

object_name: Metastatic rectal adenocarcinoma


subject: CHEBI:233362

object_name: Colorectal cancer recurrent


subject: CHEBI:233362

object_name: Stage IVB Rectal Cancer AJCC v8


subject: CHEBI:233362

object_name: Stage IVC Rectal Cancer AJCC v8


subject: CHEBI:233362

object_name: Stage IVA Rectal Cancer AJCC v8


subject: CHEBI:233362

object_name: Stage III Rectal Cancer AJCC v8


subject: CHEBI:233362

object_name: Stage IIIB Rectal Cancer AJCC v8


subject: CHEBI:233362

object_name: Stage IIIA Rectal Cancer AJCC v8


subject: CHEBI:233362

object_name: Stage IIIC Rectal Cancer AJCC v8


subject: CHEBI:233362

object_name: Unresectable Colon Adenocarcinoma


subject: CHEBI:233362

object_name: Stage IIIC Colon Cancer AJCC v8


subject: CHEBI:233362

object_name: Stage IVC Colon Cancer AJCC v8


subject: CHEBI:233362

object_name: Stage IV Colon Cancer AJCC v8


subject: CHEBI:233362

object_name: Stage IVB Colon Cancer AJCC v8


subject: CHEBI:233362

object_name: Stage IVA Colon Cancer AJCC v8


subject: CHEBI:233362

object_name: Stage III Colon Cancer AJCC v8


subject: CHEBI:233362

object_name: Stage IIIA Colon Cancer AJCC v8


subject: CHEBI:233362

object_name: Stage IIIB Colon Cancer AJCC v8


subject: UNII:PQX0D8J21J

subject_name: Cetuximab

object_name: Metastatic Colorectal Carcinoma


subject: UNII:PQX0D8J21J

object_name: Unresectable Colorectal Carcinoma


subject: UNII:PQX0D8J21J

object_name: Stage IIIC Colorectal Cancer AJCC v8


subject: UNII:PQX0D8J21J

object_name: Stage IVC Colorectal Cancer AJCC v8


subject: UNII:PQX0D8J21J

object_name: Stage IVA Colorectal Cancer AJCC v8


subject: UNII:PQX0D8J21J

object_name: Stage III Colorectal Cancer AJCC v8


subject: UNII:PQX0D8J21J

object_name: Stage IVB Colorectal Cancer AJCC v8


subject: UNII:PQX0D8J21J

object_name: Stage IIIB Colorectal Cancer AJCC v8


subject: UNII:PQX0D8J21J

object_name: Stage IIIA Colorectal Cancer AJCC v8


subject: UNII:PQX0D8J21J

object_name: Unresectable Rectal Adenocarcinoma


subject: UNII:PQX0D8J21J

object_name: Adenocarcinoma of colon metastatic


subject: UNII:PQX0D8J21J

object_name: Metastatic rectal adenocarcinoma


subject: UNII:PQX0D8J21J

object_name: Colorectal cancer recurrent


subject: UNII:PQX0D8J21J

object_name: Stage IVB Rectal Cancer AJCC v8


subject: UNII:PQX0D8J21J

object_name: Stage IVC Rectal Cancer AJCC v8


subject: UNII:PQX0D8J21J

object_name: Stage IVA Rectal Cancer AJCC v8


subject: UNII:PQX0D8J21J

object_name: Stage IIIB Rectal Cancer AJCC v8


subject: UNII:PQX0D8J21J

object_name: Stage IIIA Rectal Cancer AJCC v8


subject: UNII:PQX0D8J21J

object_name: Stage IIIC Rectal Cancer AJCC v8


subject: UNII:PQX0D8J21J

object_name: Unresectable Colon Adenocarcinoma


subject: UNII:PQX0D8J21J

object_name: Stage IIIC Colon Cancer AJCC v8


subject: UNII:PQX0D8J21J

object_name: Stage IVC Colon Cancer AJCC v8


subject: UNII:PQX0D8J21J

object_name: Stage IVB Colon Cancer AJCC v8


subject: UNII:PQX0D8J21J

object_name: Stage IVA Colon Cancer AJCC v8


subject: UNII:PQX0D8J21J

object_name: Stage IIIA Colon Cancer AJCC v8


subject: UNII:PQX0D8J21J

object_name: Stage IIIB Colon Cancer AJCC v8


subject: UMLS:C0879636

subject_name: IMC C225

object_name: Metastatic Colorectal Carcinoma


subject: UMLS:C0879636

object_name: Unresectable Colorectal Carcinoma


subject: UMLS:C0879636

object_name: Stage IIIC Colorectal Cancer AJCC v8


subject: UMLS:C0879636

object_name: Stage IVC Colorectal Cancer AJCC v8


subject: UMLS:C0879636

object_name: Stage IVA Colorectal Cancer AJCC v8


subject: UMLS:C0879636

object_name: Stage III Colorectal Cancer AJCC v8


subject: UMLS:C0879636

object_name: Stage IVB Colorectal Cancer AJCC v8


subject: UMLS:C0879636

object_name: Stage IIIB Colorectal Cancer AJCC v8


subject: UMLS:C0879636

object_name: Stage IIIA Colorectal Cancer AJCC v8


subject: UMLS:C0879636

object_name: Unresectable Rectal Adenocarcinoma


subject: UMLS:C0879636

object_name: Adenocarcinoma of colon metastatic


subject: UMLS:C0879636

object_name: Metastatic rectal adenocarcinoma


subject: UMLS:C0879636

object_name: Colorectal cancer recurrent


subject: UMLS:C0879636

object_name: Stage IVB Rectal Cancer AJCC v8


subject: UMLS:C0879636

object_name: Stage IVC Rectal Cancer AJCC v8


subject: UMLS:C0879636

object_name: Stage IVA Rectal Cancer AJCC v8


subject: UMLS:C0879636

object_name: Stage IIIB Rectal Cancer AJCC v8


subject: UMLS:C0879636

object_name: Stage IIIA Rectal Cancer AJCC v8


subject: UMLS:C0879636

object_name: Stage IIIC Rectal Cancer AJCC v8


subject: UMLS:C0879636

object_name: Unresectable Colon Adenocarcinoma


subject: UMLS:C0879636

object_name: Stage IIIC Colon Cancer AJCC v8


subject: UMLS:C0879636

object_name: Stage IVC Colon Cancer AJCC v8


subject: UMLS:C0879636

object_name: Stage IVB Colon Cancer AJCC v8


subject: UMLS:C0879636

object_name: Stage IVA Colon Cancer AJCC v8


subject: UMLS:C0879636

object_name: Stage IIIA Colon Cancer AJCC v8


subject: UMLS:C0879636

object_name: Stage IIIB Colon Cancer AJCC v8


subject: UMLS:C0082529

subject_name: Mitogen-Activated Protein Kinase 3

object_name: Metastatic Colorectal Carcinoma


subject: UMLS:C0082529

object_name: Unresectable Colorectal Carcinoma


subject: UMLS:C0082529

object_name: Stage IIIC Colorectal Cancer AJCC v8


subject: UMLS:C0082529

object_name: Stage IVC Colorectal Cancer AJCC v8


subject: UMLS:C0082529

object_name: Stage IV Colorectal Cancer AJCC v8


subject: UMLS:C0082529

object_name: Stage IVA Colorectal Cancer AJCC v8


subject: UMLS:C0082529

object_name: Stage III Colorectal Cancer AJCC v8


subject: UMLS:C0082529

object_name: Stage IVB Colorectal Cancer AJCC v8


subject: UMLS:C0082529

object_name: Stage IIIB Colorectal Cancer AJCC v8


subject: UMLS:C0082529

object_name: Stage IIIA Colorectal Cancer AJCC v8


subject: UMLS:C0082529

object_name: Unresectable Rectal Adenocarcinoma


subject: UMLS:C0082529

object_name: Adenocarcinoma of colon metastatic


subject: UMLS:C0082529

object_name: Stage IV Rectal Cancer AJCC v8


subject: UMLS:C0082529

object_name: Metastatic rectal adenocarcinoma


subject: UMLS:C0082529

object_name: Colorectal cancer recurrent


subject: UMLS:C0082529

object_name: Stage IVB Rectal Cancer AJCC v8


subject: UMLS:C0082529

object_name: Stage IVC Rectal Cancer AJCC v8


subject: UMLS:C0082529

object_name: Stage IVA Rectal Cancer AJCC v8


subject: UMLS:C0082529

object_name: Stage III Rectal Cancer AJCC v8


subject: UMLS:C0082529

object_name: Stage IIIB Rectal Cancer AJCC v8


subject: UMLS:C0082529

object_name: Stage IIIA Rectal Cancer AJCC v8


subject: UMLS:C0082529

object_name: Stage IIIC Rectal Cancer AJCC v8


subject: UMLS:C0082529

object_name: Unresectable Colon Adenocarcinoma


subject: UMLS:C0082529

object_name: Stage IIIC Colon Cancer AJCC v8


subject: UMLS:C0082529

object_name: Stage IVC Colon Cancer AJCC v8


subject: UMLS:C0082529

object_name: Stage IV Colon Cancer AJCC v8


subject: UMLS:C0082529

object_name: Stage IVB Colon Cancer AJCC v8


subject: UMLS:C0082529

object_name: Stage IVA Colon Cancer AJCC v8


subject: UMLS:C0082529

object_name: Stage III Colon Cancer AJCC v8


subject: UMLS:C0082529

object_name: Stage IIIA Colon Cancer AJCC v8


subject: UMLS:C0082529

object_name: Stage IIIB Colon Cancer AJCC v8


subject: UMLS:C0042210

subject_name: Vaccines

object_name: Ebola hemorrhagic fever


subject: UMLS:C0042210

object_name: Prevention problem


subject: UMLS:C5399710

subject_name: Vaccine [APC]


subject: UMLS:C5399710


subject: MESH:D000086663

subject_name: COVID-19 Vaccines

object_name: lung cancer


subject: MESH:D000086663

object_name: lung neoplasm


subject: MESH:D000086663

object_name: lung carcinoma


subject: UMLS:C5400806

subject_name: COVID-19 VACCINE


subject: UMLS:C5400806


subject: UMLS:C5400806


subject: CHEBI:145500

subject_name: thiencarbazone-methyl

object_name: Amputated structure (morphologic abnormality)


subject: CHEBI:145500

object_name: Diabetic foot ulcer


subject: CHEBI:35255

subject_name: Chloroform


subject: CHEBI:35255


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: Carcinoma breast stage IV


subject: UMLS:C3827082


subject: CHEBI:231679

subject_name: ipilimumab


subject: UNII:6XG22YQM2Z

subject_name: TIRAGOLUMAB


subject: UMLS:C4331912


subject: CHEBI:10033

subject_name: Warfarin

object_name: Cerebral Embolism and Thrombosis


subject: CHEBI:10033

object_name: thrombophlebitis


subject: CHEBI:10033

object_name: Arrhythmia


subject: CHEBI:47426

subject_name: Furosemide

object_name: colorectal disorders


subject: PUBCHEM.COMPOUND:9848990

subject_name: BUPRENORPHINE

object_name: Low back pain


subject: CHEBI:41423

subject_name: Celecoxib

object_name: macular degeneration


subject: CHEBI:41423

object_name: age-related macular degeneration


subject: CHEBI:41423

object_name: retinitis pigmentosa 30


subject: PUBCHEM.COMPOUND:78162481

subject_name: Lorlatinib

object_name: Metastatic non-small cell lung cancer


subject: MESH:C544151

subject_name: jinfukang

object_name: non-small cell lung carcinoma


subject: CHEBI:79699

subject_name: Temsirolimus

object_name: Stage IIIC Breast Cancer AJCC v7


subject: CHEBI:79699

object_name: Stage III Breast Cancer AJCC v7


subject: CHEBI:79699

object_name: Stage IIIB Breast Carcinoma


subject: CHEBI:79699

object_name: Stage IIIA Breast Carcinoma


subject: CHEBI:231005

subject_name: 2-(Trifluoromethyl)isonicotinic acid

object_name: soft tissue sarcoma


subject: CHEBI:63587

subject_name: Eribulin


subject: CHEBI:91397

subject_name: Ibrutinib

object_name: mantle cell lymphoma


subject: PUBCHEM.COMPOUND:1805

subject_name: Azacytidine, 5-

object_name: leukemia


subject: PUBCHEM.COMPOUND:1805

object_name: childhood leukemia


subject: CHEBI:78543

subject_name: Ponatinib


subject: CHEBI:78543


subject: MESH:D022341

subject_name: Yellow Fever Vaccine

object_name: cytotoxicity


subject: MESH:D022341

object_name: Adverse reaction to yellow fever vaccine


subject: UMLS:C5887900

subject_name: Yellow fever virus antigen only vaccine product


subject: UMLS:C5887900


subject: CHEMBL.COMPOUND:CHEMBL2108816

subject_name: YELLOW FEVER VACCINE


subject: CHEMBL.COMPOUND:CHEMBL2108816


subject: UMLS:C2356374

subject_name: yellow fever virus strain 17D-204 live antigen


subject: UMLS:C2356374


subject: CHEBI:78425

subject_name: Albiglutide

object_name: type 2 diabetes mellitus


subject: PUBCHEM.COMPOUND:3417

object_name: infective endocarditis


subject: PUBCHEM.COMPOUND:3417

object_name: bacterial endocarditis


subject: CHEBI:62247


subject: CHEBI:62247


subject: CHEBI:62419


subject: CHEBI:62419


subject: CHEBI:28915

subject_name: Fosfomycin


subject: CHEBI:28915


subject: CHEBI:51799

subject_name: Imipenem


subject: CHEBI:51799


subject: CHEBI:190509


subject: CHEBI:190509


subject: CHEBI:10127

subject_name: Zonisamide

object_name: alcohol abuse


subject: CHEBI:10127

object_name: alcohol dependence


subject: CHEBI:194095

subject_name: mitomycin C(1-)

object_name: sclerosing cholangitis


subject: CHEBI:194095

object_name: primary sclerosing cholangitis


subject: CHEBI:27504

subject_name: Mitomycin


subject: CHEBI:27504


subject: UNII:58BU988K90

subject_name: Deleobuvir

object_name: kidney failure


subject: UMLS:C3886693


subject: UNII:958X4J301A

subject_name: Faldaprevir


subject: UMLS:C3661290

subject_name: faldaprevir


subject: CHEBI:58097

object_name: Other specified disorders of kidney and ureter


subject: CHEBI:58097

object_name: nephrolithiasis


subject: CHEBI:58097

object_name: ureter cancer


subject: CHEBI:58097

object_name: ureter carcinoma


subject: CHEBI:58097

object_name: ureter benign neoplasm


subject: CHEBI:58097

object_name: Congenital anomaly of ureter


subject: CHEBI:58097

object_name: kidney benign neoplasm


subject: CHEBI:58097

object_name: renal carcinoma


subject: CHEBI:58097

object_name: kidney cancer


subject: CHEBI:58097

object_name: vesicoureteral reflux


subject: CHEBI:17303

subject_name: Morphine


subject: CHEBI:17303


subject: CHEBI:17303


subject: CHEBI:17303


subject: CHEBI:17303


subject: CHEBI:17303


subject: CHEBI:17303


subject: CHEBI:17303


subject: CHEBI:17303


subject: CHEBI:17303


subject: CHEBI:3215

subject_name: Bupivacaine


subject: CHEBI:3215


subject: CHEBI:3215


subject: CHEBI:3215


subject: CHEBI:3215


subject: CHEBI:3215


subject: CHEBI:3215


subject: CHEBI:3215


subject: CHEBI:3215


subject: UNII:9G6U5L461Q

subject_name: Icotinib

object_name: non-small cell lung carcinoma


subject: UNII:2XD9773ZMN

subject_name: Tonabersat

object_name: migraine with aura


subject: UNII:2XD9773ZMN

object_name: Common Migraine


subject: CHEBI:63633

subject_name: Triptorelin

object_name: prostate carcinoma


subject: CHEBI:63633

object_name: prostate cancer


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: Alzheimer disease


subject: CHEBI:71940

subject_name: Tadalafil

object_name: systemic sclerosis


subject: CHEBI:71940

object_name: pulmonary hypertension, primary, 1


subject: CHEBI:71940

object_name: idiopathic pulmonary arterial hypertension


subject: CHEBI:71940

object_name: pulmonary arterial hypertension


subject: CHEBI:71940

object_name: Rheumatism


subject: CHEBI:71940

object_name: connective tissue disorder


subject: UNII:72AH61702G

subject_name: Rociletinib


subject: CHEBI:232556

subject_name: Erdafitinib

object_name: FGFR3 gene mutation


subject: CHEBI:232556

object_name: bladder tumor


subject: CHEBI:232556

object_name: urinary bladder carcinoma


subject: CHEBI:232556

object_name: urinary bladder cancer


subject: CHEBI:232556

object_name: childhood bladder carcinoma


subject: CHEBI:232556

object_name: Bladder cancer recurrent


subject: UMLS:C2726511

subject_name: Wilate

object_name: hemophilia A


subject: UMLS:C4074414

subject_name: Nuwiq


subject: CHEBI:90936

subject_name: Alectinib

object_name: cancer


subject: CHEBI:90936

object_name: neoplastic syndrome


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab


subject: UNII:52CMI0WC3Y


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UNII:KXG2PJ551I

subject_name: Avelumab


subject: UNII:KXG2PJ551I

object_name: neoplasm


subject: UNII:KXG2PJ551I


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: CHEBI:66910

subject_name: Axitinib


subject: CHEBI:66910


subject: CHEBI:66910


subject: CHEBI:114785

subject_name: Erlotinib


subject: CHEBI:114785


subject: CHEBI:177298


subject: CHEBI:177298


subject: CHEBI:177298


subject: CHEBI:176844

subject_name: Niraparib


subject: CHEBI:176844


subject: CHEBI:176844


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UMLS:C2826229


subject: UMLS:C2826229


subject: UMLS:C2826229


subject: CHEBI:231601

subject_name: trastuzumab


subject: CHEBI:231601


subject: UMLS:C0338204

subject_name: Herceptin


subject: UMLS:C0338204


subject: UNII:K16AIQ8CTM

subject_name: Pertuzumab


subject: UNII:K16AIQ8CTM


subject: CHEBI:63637

subject_name: Vemurafenib


subject: CHEBI:63637


subject: PUBCHEM.COMPOUND:51038893

subject_name: Cobimetinib


subject: PUBCHEM.COMPOUND:51038893


subject: CHEBI:66903

subject_name: Vismodegib


subject: CHEBI:66903


subject: UNII:2Y3T5IF01Z

subject_name: Retifanlimab

object_name: Adult Penile Carcinoma


subject: UNII:2Y3T5IF01Z

object_name: penis carcinoma


subject: UNII:2Y3T5IF01Z

object_name: penile cancer


subject: UMLS:C4688466

subject_name: INCMGA 0012


subject: UMLS:C4688466


subject: UMLS:C4688466


subject: CHEBI:23359

subject_name: colchicine

object_name: acute coronary syndrome


subject: CHEBI:27812

subject_name: Methylselenocysteine

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: CHEBI:27812

object_name: amyotrophic lateral sclerosis


subject: UMLS:C1705207

subject_name: Endostar

object_name: non-small cell lung carcinoma


subject: UNII:WBX54NZ436

object_name: Myelodysplasia


subject: UNII:WBX54NZ436

object_name: Adult Myelodysplastic Syndrome


subject: UNII:WBX54NZ436

object_name: childhood myelodysplastic syndrome


subject: UNII:WBX54NZ436

object_name: Myelodysplastic Syndrome, CTCAE


subject: UNII:WBX54NZ436

object_name: beta thalassemia major anemia


subject: CHEBI:168442

subject_name: Urolithin A

object_name: Frailty


subject: CHEBI:168442

object_name: Muscle Atrophy


subject: CHEBI:168442

object_name: sarcopenia


subject: CHEBI:50634

object_name: contrast-induced nephropathy


subject: CHEBI:27690

subject_name: Acetazolamide


subject: CHEBI:8228

subject_name: Pioglitazone

object_name: adrenogenital syndrome


subject: CHEBI:8228

object_name: congenital adrenal hyperplasia


subject: UNII:V5Y646AW8S

object_name: attention deficit hyperactivity disorder, inattentive type


subject: UNII:V5Y646AW8S


subject: CHEBI:2618

subject_name: Amantadine


subject: CHEBI:2618


subject: CHEBI:6538

subject_name: Loratadine


subject: CHEBI:6538


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil

object_name: Leukokeratosis


subject: CHEBI:190410

subject_name: 13-Demethyl tacrolimus


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:6931

subject_name: Midazolam

object_name: Nonulcer dyspepsia


subject: CHEBI:6931

object_name: gastritis


subject: CHEBI:6931

object_name: Gastritis, CTCAE


subject: CHEBI:119915

subject_name: Fentanyl


subject: CHEBI:119915


subject: CHEBI:119915


subject: CHEBI:44915

subject_name: Propofol


subject: CHEBI:44915


subject: CHEBI:44915


subject: UNII:ZE15FIT23E

subject_name: ranpirnase

object_name: non-small cell lung carcinoma


subject: UMLS:C0069919


subject: UMLS:C4547969

subject_name: apatinib mesylate

object_name: liver carcinoma


subject: CHEBI:85994

subject_name: Lenvatinib

object_name: Advanced gastric carcinoma


subject: UMLS:C0684259

subject_name: Humatrope

object_name: Turner syndrome


subject: UMLS:C5222462

subject_name: Liraglutide Injection

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UMLS:C5222462

object_name: obesity


subject: UMLS:C5222462

object_name: Obesity, CTCAE


subject: CHEBI:59062

subject_name: polymyxin

object_name: rhegmatogenous retinal detachment


subject: UMLS:C0032539

subject_name: Polymyxins


subject: CHEBI:74705

subject_name: Met-Leu


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin


subject: CHEBI:9150

subject_name: Simvastatin

object_name: bipolar disorder


subject: UMLS:C5706457

subject_name: Anti-CD39 Antibody/TGF-beta RII Ectodomain Fusion Protein ES014

object_name: Childhood Solid Neoplasm


subject: UMLS:C5706457

object_name: Adult Solid Neoplasm


subject: UMLS:C5706457

object_name: Solid Neoplasm


subject: UMLS:C5706457

object_name: Metastatic Malignant Solid Neoplasm


subject: UMLS:C5706457

object_name: Locally Advanced Malignant Solid Neoplasm


subject: CHEBI:63043

object_name: aortic valve disease 2


subject: CHEBI:63043

object_name: aortic stenosis


subject: CHEBI:63043

object_name: aortic valve disease 3


subject: CHEBI:63043

object_name: Stenosis of aorta


subject: UNII:R8DG7T2D3A

subject_name: FERUMOXYTOL

object_name: anemia


subject: UNII:R8DG7T2D3A

object_name: Anemia, CTCAE


subject: UNII:CLH5FT6412

subject_name: Ferumoxytol


subject: UNII:CLH5FT6412


subject: CHEBI:46726

subject_name: magnetite


subject: CHEBI:46726


subject: CHEBI:4445

subject_name: Desflurane

object_name: Postoperative Complications


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: carcinoma of biliary tract


subject: PUBCHEM.COMPOUND:2767

object_name: gallbladder carcinoma


subject: CHEBI:175901

subject_name: Gemcitabine


subject: CHEBI:175901


subject: CHEBI:90227

subject_name: Selumetinib


subject: CHEBI:90227


subject: CHEBI:10588

subject_name: m-Chlorophenylpiperazine

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:10588

object_name: obesity


subject: CHEBI:10588

object_name: Obesity, CTCAE


subject: CHEBI:75704

subject_name: mecoprop


subject: CHEBI:75704


subject: CHEBI:75704


subject: CHEBI:85990

subject_name: Panobinostat

object_name: acute myeloid leukemia by FAB classification


subject: CHEBI:85990

object_name: acute myeloid leukemia


subject: CHEBI:78351

subject_name: amantadine sulfate

object_name: coma; prolonged


subject: CHEBI:2618

subject_name: Amantadine


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina

object_name: stage, colon cancer


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: UMLS:C3265062


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:64073

object_name: short bowel syndrome


subject: UNII:9P1872D4OL

subject_name: Exenatide


subject: PUBCHEM.COMPOUND:78162481

subject_name: Lorlatinib

object_name: metastatic malignant neoplasm in the brain


subject: PUBCHEM.COMPOUND:78162481

object_name: neoplastic meningitis


subject: GTOPDB:11601

subject_name: olokizumab

object_name: rheumatoid arthritis


subject: CHEMBL.COMPOUND:CHEMBL1743050

subject_name: OLOKIZUMAB


subject: CHEBI:9139

subject_name: Sildenafil

object_name: Central venous pressure - finding


subject: CHEBI:9139

object_name: Hemodynamic instability


subject: CHEMBL.COMPOUND:CHEMBL3833369

subject_name: FISH OIL

object_name: end stage renal failure


subject: CHEMBL.COMPOUND:CHEMBL3833369

object_name: Chronic uremia


subject: CHEBI:6888

subject_name: Methylprednisolone

object_name: Post-Operative Pain


subject: CHEBI:6888

object_name: post operative nausea and vomiting


subject: CHEBI:6888

object_name: Inflammatory Response


subject: CHEBI:6888

object_name: Fatigue, CTCAE 5.0


subject: CHEBI:6888

object_name: Fatigue


subject: CHEBI:4672

subject_name: Docetaxel

object_name: triple-negative breast carcinoma


subject: CHEBI:4672

object_name: Triple-Negative Breast Cancer Finding


subject: CHEBI:131168

subject_name: Afuresertib

object_name: cancer


subject: CHEBI:131168

object_name: neoplasm


subject: CHEBI:17596

subject_name: Inosine

object_name: pulmonary embolism


subject: CHEBI:17596

object_name: Subacute massive pulmonary embolism


subject: CHEBI:16411

subject_name: Indoleacetic acid


subject: CHEBI:16411


subject: UNII:2261HH611H

subject_name: Tenalisib

object_name: Hodgkin Disease


subject: UNII:2261HH611H

object_name: Adult Classical Hodgkin Lymphoma


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: brain neoplasm


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: DRUGBANK:DB11097

subject_name: Plantago seed

object_name: Impaired fasting glucose


subject: CHEBI:165446

subject_name: Psyllic acid


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim

object_name: Supratentorial Gliosarcoma


subject: UNII:PVI5M0M1GW

object_name: glioblastoma


subject: UNII:PVI5M0M1GW

object_name: Brain Stem Glioblastoma


subject: UNII:PVI5M0M1GW

object_name: glioma susceptibility 1


subject: UNII:PVI5M0M1GW

object_name: Supratentorial Glioblastoma


subject: UNII:PVI5M0M1GW

object_name: adult glioblastoma


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: UNII:01KC87F8FE


subject: UNII:01KC87F8FE


subject: UNII:01KC87F8FE


subject: UNII:01KC87F8FE


subject: UNII:01KC87F8FE


subject: UNII:01KC87F8FE


subject: CHEBI:3423

subject_name: Carmustine


subject: CHEBI:3423


subject: CHEBI:3423


subject: CHEBI:3423


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED


subject: UMLS:C0919079


subject: CHEBI:72564

subject_name: Temozolomide


subject: CHEBI:72564


subject: UMLS:C2742210

object_name: DS Stage II Plasma Cell Myeloma


subject: UMLS:C2742210

object_name: DS Stage I Plasma Cell Myeloma


subject: UMLS:C2742210

object_name: Plasma cell myeloma refractory


subject: UMLS:C2742210

object_name: DS Stage III Plasma Cell Myeloma


subject: CHEBI:82339

subject_name: Merphalan


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:28876

subject_name: Melphalan


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:8228

subject_name: Pioglitazone

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: CHEBI:8228

object_name: amyotrophic lateral sclerosis


subject: CHEBI:15367

subject_name: Tretinoin


subject: CHEBI:15367


subject: CHEBI:50648

subject_name: Alitretinoin


subject: CHEBI:50648


subject: CHEBI:32296

subject_name: vinorelbine L-tartrate

object_name: Childhood Breast Carcinoma


subject: CHEBI:32296

object_name: breast carcinoma


subject: CHEBI:32296

object_name: breast cancer


subject: PUBCHEM.COMPOUND:16051941


subject: PUBCHEM.COMPOUND:16051941


subject: PUBCHEM.COMPOUND:16051941


subject: CHEBI:53750

subject_name: vinorelbine D-tartrate


subject: CHEBI:53750


subject: CHEBI:53750


subject: UNII:N24015WC6D

subject_name: Atevirdine

object_name: hepatitis C


subject: UNII:N24015WC6D

object_name: HIV infection


subject: CHEBI:37924

subject_name: Atazanavir


subject: CHEBI:73501

subject_name: Glu-Phe-Val


subject: CHEBI:119486

subject_name: Efavirenz


subject: CHEBI:173106

subject_name: ferroptocide


subject: CHEBI:31536

subject_name: Emtricitabine


subject: CHEBI:63717

subject_name: Tenofovir disoproxil


subject: CHEBI:63625

subject_name: Tenofovir


subject: UniProtKB:P36394

subject_name: SRY_RAT Sex-determining region Y protein (sprot)


subject: PR:000015643

subject_name: sex-determining region Y protein


subject: CHEBI:30742

subject_name: macrogol


subject: PR:000012224

subject_name: glycodelin


subject: CHEBI:8772

subject_name: Raloxifene


subject: CHEBI:8772


subject: PR:000013695

subject_name: Ras-related protein Ral-A


subject: PR:000013695


subject: PR:000022493


subject: CHEBI:10110

subject_name: Zidovudine


subject: CHEBI:63577

subject_name: Lamivudine


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Mature B-Cell Non-Hodgkin Lymphoma


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:143658


subject: CHEBI:28445

subject_name: vincristine


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide


subject: CHEBI:28680

subject_name: Cytarabine


subject: CHEBI:8382

subject_name: Prednisone


subject: CHEBI:5864

subject_name: Ifosfamide


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:93775

subject_name: Amethopterin


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UMLS:C0295415

subject_name: rituximab


subject: UNII:UC95NQ339C

subject_name: BOTULINUM TOXIN

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UNII:UC95NQ339C

object_name: obesity


subject: UNII:UC95NQ339C

object_name: Obesity, CTCAE


subject: UMLS:C0006055

subject_name: Botulinum Toxins


subject: UMLS:C0006055


subject: UMLS:C0006055


subject: CHEBI:7465

subject_name: Naltrexone

object_name: Self-injurious behavior


subject: CHEBI:7465

object_name: Self-mutilation


subject: CHEBI:3766

subject_name: Clozapine

object_name: schizoaffective disorder


subject: CHEBI:3766

object_name: schizophrenia 18


subject: CHEBI:68646

subject_name: REGORAFENIB

object_name: thyroid tumor


subject: CHEBI:68646

object_name: thyroid gland carcinoma


subject: CHEBI:68646

object_name: thyroid cancer


subject: CHEBI:68647

subject_name: Regorafenib


subject: CHEBI:68647


subject: CHEBI:68647


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: plasma cell myeloma


subject: UMLS:C1508755

object_name: Alzheimer disease


subject: CHEBI:145499

subject_name: Donepezil


subject: UMLS:C3181238

subject_name: focetria

object_name: Rheumatism


subject: UMLS:C3181238

object_name: influenza


subject: CHEBI:201431

subject_name: Cyclosporin H

object_name: hepatitis C


subject: CHEBI:4031

subject_name: Cyclosporine


subject: UNII:N3858377KC

object_name: Pancreatic Neuroendocrine Tumor G2


subject: UNII:N3858377KC

object_name: pancreatic neuroendocrine tumor G1


subject: UNII:N3858377KC

object_name: Digestive System Neuroendocrine Tumor G2


subject: UNII:N3858377KC

object_name: Gastrointestinal Carcinoid Tumor


subject: UNII:N3858377KC

object_name: Metastatic malignant neoplasm to liver


subject: UNII:N3858377KC

object_name: Metastatic Digestive System Neuroendocrine Neoplasm